S 283 IS
107th CONGRESS
1st Session
S. 283
To amend the Public Health Service Act, the Employee Retirement
Income Security Act of 1974, and the Internal Revenue Code of 1986 to protect
consumers in managed care plans and other health coverage.
IN THE SENATE OF THE UNITED STATES
February 7, 2001
Mr. MCCAIN (for himself, Mr. EDWARDS, Mr. KENNEDY, Mr. CHAFEE, Mr. GRAHAM,
Mr. SPECTER, Mrs. LINCOLN, Mr. HARKIN, Mr. BAUCUS, Mr. TORRICELLI, Mr. DODD, Mr.
NELSON of Florida, Mr. SCHUMER, and Mr. CORZINE) introduced the following bill;
which was read twice and referred to the Committee on Health, Education, Labor,
and Pensions
A BILL
To amend the Public Health Service Act, the Employee Retirement
Income Security Act of 1974, and the Internal Revenue Code of 1986 to protect
consumers in managed care plans and other health coverage.
Be it enacted by the Senate and House of Representatives of the United
States of America in Congress assembled,
SECTION 1. SHORT TITLE; TABLE OF CONTENTS.
(a) SHORT TITLE- This Act may be cited as the `Bipartisan Patient
Protection Act of 2001'.
(b) TABLE OF CONTENTS- The table of contents of this Act is as follows:
Sec. 1. Short title; table of contents.
TITLE I--IMPROVING MANAGED CARE
Subtitle A--Utilization Review; Claims; and Internal and External
Appeals
Sec. 101. Utilization review activities.
Sec. 102. Procedures for initial claims for benefits and prior
authorization determinations.
Sec. 103. Internal appeals of claims denials.
Sec. 104. Independent external appeals procedures.
Subtitle B--Access to Care
Sec. 111. Consumer choice option.
Sec. 112. Choice of health care professional.
Sec. 113. Access to emergency care.
Sec. 114. Timely access to specialists.
Sec. 115. Patient access to obstetrical and gynecological care.
Sec. 116. Access to pediatric care.
Sec. 117. Continuity of care.
Sec. 118. Access to needed prescription drugs.
Sec. 119. Coverage for individuals participating in approved clinical
trials.
Sec. 120. Required coverage for minimum hospital stay for mastectomies
and lymph node dissections for the treatment of breast cancer and coverage
for secondary consultations.
Subtitle C--Access to Information
Sec. 121. Patient access to information.
Subtitle D--Protecting the Doctor-Patient Relationship
Sec. 131. Prohibition of interference with certain medical
communications.
Sec. 132. Prohibition of discrimination against providers based on
licensure.
Sec. 133. Prohibition against improper incentive arrangements.
Sec. 134. Payment of claims.
Sec. 135. Protection for patient advocacy.
Subtitle E--Definitions
Sec. 152. Preemption; State flexibility; construction.
Sec. 154. Coverage of limited scope plans.
Sec. 156. Incorporation into plan or coverage documents.
TITLE II--APPLICATION OF QUALITY CARE STANDARDS TO GROUP HEALTH PLANS AND
HEALTH INSURANCE COVERAGE UNDER THE PUBLIC HEALTH SERVICE ACT
Sec. 201. Application to group health plans and group health insurance
coverage.
Sec. 202. Application to individual health insurance coverage.
TITLE III--AMENDMENTS TO THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF
1974
Sec. 301. Application of patient protection standards to group health
plans and group health insurance coverage under the Employee Retirement
Income Security Act of 1974.
Sec. 302. Availability of civil remedies.
Sec. 303. Limitations on actions.
TITLE IV--AMENDMENTS TO THE INTERNAL REVENUE CODE OF 1986
Sec. 401. Application of requirements to group health plans under the
Internal Revenue Code of 1986.
Sec. 402. Conforming enforcement for women's health and cancer
rights.
TITLE V--EFFECTIVE DATES; COORDINATION IN IMPLEMENTATION
Sec. 501. Effective dates.
Sec. 502. Coordination in implementation.
TITLE I--IMPROVING MANAGED CARE
Subtitle A--Utilization Review; Claims; and Internal and External
Appeals
SEC. 101. UTILIZATION REVIEW ACTIVITIES.
(a) COMPLIANCE WITH REQUIREMENTS-
(1) IN GENERAL- A group health plan, and a health insurance issuer that
provides health insurance coverage, shall conduct utilization review
activities in connection with the provision of benefits under such plan or
coverage only in accordance with a utilization review program that meets the
requirements of this section and section 102.
(2) USE OF OUTSIDE AGENTS- Nothing in this section shall be construed as
preventing a group health plan or health insurance issuer from arranging
through a contract or otherwise for persons or entities to conduct
utilization review activities on behalf of the plan or issuer, so long as
such activities are conducted in accordance with a utilization review
program that meets the requirements of this section.
(3) UTILIZATION REVIEW DEFINED- For purposes of this section, the terms
`utilization review' and `utilization review activities' mean procedures
used to monitor or evaluate the use or coverage, clinical necessity,
appropriateness, efficacy, or efficiency of health care services, procedures
or settings, and includes prospective review, concurrent review, second
opinions, case management, discharge planning, or retrospective
review.
(b) WRITTEN POLICIES AND CRITERIA-
(1) WRITTEN POLICIES- A utilization review program shall be conducted
consistent with written policies and procedures that govern all aspects of
the program.
(2) USE OF WRITTEN CRITERIA-
(A) IN GENERAL- Such a program shall utilize written clinical review
criteria developed with input from a range of appropriate actively
practicing health care professionals, as determined by the plan, pursuant
to the program.
Such criteria shall include written clinical review criteria that are based
on valid clinical evidence where available and that are directed specifically at
meeting the needs of at-risk populations and covered individuals with chronic
conditions or severe illnesses, including gender-specific criteria and
pediatric-specific criteria where available and appropriate.
(B) CONTINUING USE OF STANDARDS IN RETROSPECTIVE REVIEW- If a health
care service has been specifically pre-authorized or approved for a
participant, beneficiary, or enrollee under such a program, the program
shall not, pursuant to retrospective review, revise or modify the specific
standards, criteria, or procedures used for the utilization review for
procedures, treatment, and services delivered to the enrollee during the
same course of treatment.
(C) REVIEW OF SAMPLE OF CLAIMS DENIALS- Such a program shall provide
for a periodic evaluation of the clinical appropriateness of at least a
sample of denials of claims for benefits.
(c) CONDUCT OF PROGRAM ACTIVITIES-
(1) ADMINISTRATION BY HEALTH CARE PROFESSIONALS- A utilization review
program shall be administered by qualified health care professionals who
shall oversee review decisions.
(2) USE OF QUALIFIED, INDEPENDENT PERSONNEL-
(A) IN GENERAL- A utilization review program shall provide for the
conduct of utilization review activities only through personnel who are
qualified and have received appropriate training in the conduct of such
activities under the program.
(B) PROHIBITION OF CONTINGENT COMPENSATION ARRANGEMENTS- Such a
program shall not, with respect to utilization review activities, permit
or provide compensation or anything of value to its employees, agents, or
contractors in a manner that encourages denials of claims for
benefits.
(C) PROHIBITION OF CONFLICTS- Such a program shall not permit a health
care professional who is providing health care services to an individual
to perform utilization review activities in connection with the health
care services being provided to the individual.
(3) ACCESSIBILITY OF REVIEW- Such a program shall provide that
appropriate personnel performing utilization review activities under the
program, including the utilization review administrator, are reasonably
accessible by toll-free telephone during normal business hours to discuss
patient care and allow response to telephone requests, and that appropriate
provision is made to receive and respond promptly to calls received during
other hours.
(4) LIMITS ON FREQUENCY- Such a program shall not provide for the
performance of utilization review activities with respect to a class of
services furnished to an individual more frequently than is reasonably
required to assess whether the services under review are medically necessary
and appropriate.
SEC. 102. PROCEDURES FOR INITIAL CLAIMS FOR BENEFITS AND PRIOR AUTHORIZATION
DETERMINATIONS.
(a) PROCEDURES OF INITIAL CLAIMS FOR BENEFITS-
(1) IN GENERAL- A group health plan, or health insurance issuer offering
health insurance coverage, shall--
(A) make a determination on an initial claim for benefits by a
participant, beneficiary, or enrollee (or authorized representative)
regarding payment or coverage for items or services under the terms and
conditions of the plan or coverage involved, including any cost-sharing
amount that the participant, beneficiary, or enrollee is required to pay
with respect to such claim for benefits; and
(B) notify a participant, beneficiary, or enrollee (or authorized
representative) and the treating health care professional involved
regarding a determination on an initial claim for benefits made under the
terms and conditions of the plan or coverage, including any cost-sharing
amounts that the participant, beneficiary, or enrollee may be required to
make with respect to such claim for benefits, and of the right of the
participant, beneficiary, or enrollee to an internal appeal under section
103.
(2) ACCESS TO INFORMATION-
(A) TIMELY PROVISION OF NECESSARY INFORMATION- With respect to an
initial claim for benefits, the participant, beneficiary, or enrollee (or
authorized representative) and the
treating health care professional (if any) shall provide the plan or issuer
with access to information requested by the plan or issuer that is necessary to
make a determination relating to the claim. Such access shall be provided not
later than 5 days after the date on which the request for information is
received, or, in a case described in subparagraph (B) or (C) of subsection
(b)(1), by such earlier time as may be necessary to comply with the applicable
timeline under such subparagraph.
(B) LIMITED EFFECT OF FAILURE ON PLAN OR ISSUER'S OBLIGATIONS- Failure
of the participant, beneficiary, or enrollee to comply with the
requirements of subparagraph (A) shall not remove the obligation of the
plan or issuer to make a decision in accordance with the medical
exigencies of the case and as soon as possible, based on the available
information, and failure to comply with the time limit established by this
paragraph shall not remove the obligation of the plan or issuer to comply
with the requirements of this section.
(3) ORAL REQUESTS- In the case of a claim for benefits involving an
expedited or concurrent determination, a participant, beneficiary, or
enrollee (or authorized representative) may make an initial claim for
benefits orally, but a group health plan, or health insurance issuer
offering health insurance coverage, may require that the participant,
beneficiary, or enrollee (or authorized representative) provide written
confirmation of such request in a timely manner on a form provided by the
plan or issuer. In the case of such an oral request for benefits, the making
of the request (and the timing of such request) shall be treated as the
making at that time of a claims for such benefits without regard to whether
and when a written confirmation of such request is made.
(b) TIMELINE FOR MAKING DETERMINATIONS-
(1) PRIOR AUTHORIZATION DETERMINATION-
(A) IN GENERAL- A group health plan, or health insurance issuer
offering health insurance coverage, shall make a prior authorization
determination on a claim for benefits (whether oral or written) in
accordance with the medical exigencies of the case and as soon as
possible, but in no case later than 14 days from the date on which the
plan or issuer receives information that is reasonably necessary to enable
the plan or issuer to make a determination on the request for prior
authorization and in no case later than 28 days after the date of the
claim for benefits is received.
(B) EXPEDITED DETERMINATION- Notwithstanding subparagraph (A), a group
health plan, or health insurance issuer offering health insurance
coverage, shall expedite a prior authorization determination on a claim
for benefits described in such subparagraph when a request for such an
expedited determination is made by a participant, beneficiary, or enrollee
(or authorized representative) at any time during the process for making a
determination and a health care professional certifies, with the request,
that a determination under the procedures described in subparagraph (A)
would seriously jeopardize the life or health of the participant,
beneficiary, or enrollee or the ability of the participant, beneficiary,
or enrollee to maintain or regain maximum function. Such determination
shall be made in accordance with the medical exigencies of the case and as
soon as possible, but in no case later than 72 hours after the time the
request is received by the plan or issuer under this
subparagraph.
(I) IN GENERAL- Subject to clause (ii), in the case of a
concurrent review of ongoing care (including hospitalization), which
results in a termination or reduction of such care, the plan or issuer
must provide by telephone and in printed form notice of the concurrent
review determination to the individual or the individual's designee
and the individual's health care provider in accordance with the
medical exigencies of the case and as soon as possible, with
sufficient time prior to the termination or reduction to allow for an
appeal under section 103(b)(3) to be completed before the termination
or reduction takes effect.
(II) CONTENTS OF NOTICE- Such notice shall include, with respect
to ongoing health care items and services, the number of ongoing
services approved, the new total of approved services, the date of
onset of services, and the next review date, if any, as well as a
statement of the individual's rights to further appeal.
(ii) RULE OF CONSTRUCTION- Clause (i) shall not be construed as
requiring plans or issuers to provide coverage of care that would exceed
the coverage limitations for such care.
(2) RETROSPECTIVE DETERMINATION- A group health plan, or health
insurance issuer offering health insurance coverage, shall make a
retrospective determination on a claim for benefits in accordance with the
medical exigencies of the case and as soon as possible, but not later than
30 days after the date on which the plan or issuer receives information that
is reasonably necessary to enable the plan or issuer to make a determination
on the claim, or, if earlier, 60 days after the date of receipt of the claim
for benefits.
(c) NOTICE OF A DENIAL OF A CLAIM FOR BENEFITS- Written notice of a denial
made under an initial claim for benefits shall be issued to the participant,
beneficiary, or enrollee (or authorized representative) and the
treating health care professional in accordance with the medical exigencies
of the case and as soon as possible, but in no case later than 2 days after the
date of the determination (or, in the case described in subparagraph (B) or (C)
of subsection (b)(1), within the 72-hour or applicable period referred to in
such subparagraph).
(d) REQUIREMENTS OF NOTICE OF DETERMINATIONS- The written notice of a
denial of a claim for benefits determination under subsection (c) shall be
provided in printed form and written in a manner calculated to be understood
by the average participant, beneficiary, or enrollee and shall include--
(1) the specific reasons for the determination (including a summary of
the clinical or scientific evidence used in making the determination);
(2) the procedures for obtaining additional information concerning the
determination; and
(3) notification of the right to appeal the determination and
instructions on how to initiate an appeal in accordance with section
103.
(e) DEFINITIONS- For purposes of this part:
(1) AUTHORIZED REPRESENTATIVE- The term `authorized representative'
means, with respect to an individual who is a participant, beneficiary, or
enrollee, any health care professional or other person acting on behalf of
the individual with the individual's consent or without such consent if the
individual is medically unable to provide such consent.
(2) CLAIM FOR BENEFITS- The term `claim for benefits' means any request
for coverage (including authorization of coverage), for eligibility, or for
payment in whole or in part, for an item or service under a group health
plan or health insurance coverage.
(3) DENIAL OF CLAIM FOR BENEFITS- The term `denial' means, with respect
to a claim for benefits, a denial (in whole or in part) of, or a failure to
act on a timely basis upon, the claim for benefits and includes a failure to
provide benefits (including items and services) required to be provided
under this title.
(4) TREATING HEALTH CARE PROFESSIONAL- The term `treating health care
professional' means, with respect to services to be provided to a
participant, beneficiary, or enrollee, a health care professional who is
primarily responsible for delivering those services to the participant,
beneficiary, or enrollee.
SEC. 103. INTERNAL APPEALS OF CLAIMS DENIALS.
(a) RIGHT TO INTERNAL APPEAL-
(1) IN GENERAL- A participant, beneficiary, or enrollee (or authorized
representative) may appeal any denial of a claim for benefits under section
102 under the procedures described in this section.
(A) IN GENERAL- A group health plan, or health insurance issuer
offering health insurance coverage, shall ensure that a participant,
beneficiary, or enrollee (or authorized representative) has a period of
not less than 180 days beginning on the date of a denial of a claim for
benefits under section 102 in which to appeal such denial under this
section.
(B) DATE OF DENIAL- For purposes of subparagraph (A), the date of the
denial shall be deemed to be the date as of which the participant,
beneficiary, or enrollee knew of the denial of the claim for
benefits.
(3) FAILURE TO ACT- The failure of a plan or issuer to issue a
determination on a claim for benefits under section 102 within the
applicable timeline established for such a determination under such section
is a denial of a claim for benefits for purposes this subtitle as of the
date of the applicable deadline.
(4) PLAN WAIVER OF INTERNAL REVIEW- A group health plan, or health
insurance issuer offering health insurance coverage, may waive the internal
review process under this section. In such case the plan or issuer shall
provide notice to the participant, beneficiary, or enrollee (or authorized
representative) involved, the participant, beneficiary, or enrollee (or
authorized representative) involved shall be relieved of any obligation to
complete the internal review involved, and may, at the option of such
participant, beneficiary, enrollee, or representative proceed directly to
seek further appeal through external review under section 104 or
otherwise.
(b) TIMELINES FOR MAKING DETERMINATIONS-
(1) ORAL REQUESTS- In the case of an appeal of a denial of a claim for
benefits under this section that involves an expedited or concurrent
determination, a participant, beneficiary, or enrollee (or authorized
representative) may request such appeal orally. A group health plan, or
health insurance issuer offering health insurance coverage, may require that
the participant, beneficiary, or enrollee (or authorized representative)
provide written confirmation of such request in a timely manner on a form
provided by the plan or issuer. In the case of
such an oral request for an appeal of a denial, the making of the request
(and the timing of such request) shall be treated as the making at that time of
a request for an appeal without regard to whether and when a written
confirmation of such request is made.
(2) ACCESS TO INFORMATION-
(A) TIMELY PROVISION OF NECESSARY INFORMATION- With respect to an
appeal of a denial of a claim for benefits, the participant, beneficiary,
or enrollee (or authorized representative) and the treating health care
professional (if any) shall provide the plan or issuer with access to
information requested by the plan or issuer that is necessary to make a
determination relating to the appeal. Such access shall be provided not
later than 5 days after the date on which the request for information is
received, or, in a case described in subparagraph (B) or (C) of paragraph
(3), by such earlier time as may be necessary to comply with the
applicable timeline under such subparagraph.
(B) LIMITED EFFECT OF FAILURE ON PLAN OR ISSUER'S OBLIGATIONS- Failure
of the participant, beneficiary, or enrollee to comply with the
requirements of subparagraph (A) shall not remove the obligation of the
plan or issuer to make a decision in accordance with the medical
exigencies of the case and as soon as possible, based on the available
information, and failure to comply with the time limit established by this
paragraph shall not remove the obligation of the plan or issuer to comply
with the requirements of this section.
(3) PRIOR AUTHORIZATION DETERMINATIONS-
(A) IN GENERAL- A group health plan, or health insurance issuer
offering health insurance coverage, shall make a determination on an
appeal of a denial of a claim for benefits under this subsection in
accordance with the medical exigencies of the case and as soon as
possible, but in no case later than 14 days from the date on which the
plan or issuer receives information that is reasonably necessary to enable
the plan or issuer to make a determination on the appeal and in no case
later than 28 days after the date the request for the appeal is
received.
(B) EXPEDITED DETERMINATION- Notwithstanding subparagraph (A), a group
health plan, or health insurance issuer offering health insurance
coverage, shall expedite a prior authorization determination on an appeal
of a denial of a claim for benefits described in subparagraph (A), when a
request for such an expedited determination is made by a participant,
beneficiary, or enrollee (or authorized representative) at any time during
the process for making a determination and a health care professional
certifies, with the request, that a determination under the procedures
described in subparagraph (A) would seriously jeopardize the life or
health of the participant, beneficiary, or enrollee or the ability of the
participant, beneficiary, or enrollee to maintain or regain maximum
function. Such determination shall be made in accordance with the medical
exigencies of the case and as soon as possible, but in no case later than
72 hours after the time the request for such appeal is received by the
plan or issuer under this subparagraph.
(C) ONGOING CARE DETERMINATIONS-
(i) IN GENERAL- Subject to clause (ii), in the case of a concurrent
review determination described in section 102(b)(1)(C)(i)(I), which
results in a termination or reduction of such care, the plan or issuer
must provide notice of the determination on the appeal under this
section by telephone and in printed form to the individual or the
individual's designee and the individual's health care provider in
accordance with the medical exigencies of the case and as soon as
possible, with sufficient time prior to the termination or reduction to
allow for an external appeal under section 104 to be completed before
the termination or reduction takes effect.
(ii) RULE OF CONSTRUCTION- Clause (i) shall not be construed as
requiring plans or issuers to provide coverage of care that would exceed
the coverage limitations for such care.
(4) RETROSPECTIVE DETERMINATION- A group health plan, or health
insurance issuer offering health insurance coverage, shall make a
retrospective determination on an appeal of a claim for
benefits in no case later than 30 days after the date on which the plan or
issuer receives necessary information that is reasonably necessary to enable the
plan or issuer to make a determination on the appeal and in no case later than
60 days after the date the request for the appeal is received.
(1) IN GENERAL- A review of a denial of a claim for benefits under this
section shall be conducted by an individual with appropriate expertise who
was not involved in the initial determination.
(2) REVIEW OF MEDICAL DECISIONS BY PHYSICIANS- A review of an appeal of
a denial of a claim for benefits that is based on a lack of medical
necessity and appropriateness, or based on an experimental or
investigational treatment, or requires an evaluation of medical facts, shall
be made by a physician (allopathic or osteopathic) with appropriate
expertise (including, in the case of a child, appropriate pediatric
expertise) who was not involved in the initial determination.
(d) NOTICE OF DETERMINATION-
(1) IN GENERAL- Written notice of a determination made under an internal
appeal of a denial of a claim for benefits shall be issued to the
participant, beneficiary, or enrollee (or authorized representative) and the
treating health care professional in accordance with the medical exigencies
of the case and as soon as possible, but in no case later than 2 days after
the date of completion of the review (or, in the case described in
subparagraph (B) or (C) of subsection (b)(3), within the 72-hour or
applicable period referred to in such subparagraph).
(2) FINAL DETERMINATION- The decision by a plan or issuer under this
section shall be treated as the final determination of the plan or issuer on
a denial of a claim for benefits. The failure of a plan or issuer to issue a
determination on an appeal of a denial of a claim for benefits under this
section within the applicable timeline established for such a determination
shall be treated as a final determination on an appeal of a denial of a
claim for benefits for purposes of proceeding to external review under
section 104.
(3) REQUIREMENTS OF NOTICE- With respect to a determination made under
this section, the notice described in paragraph (1) shall be provided in
printed form and written in a manner calculated to be understood by the
average participant, beneficiary, or enrollee and shall include--
(A) the specific reasons for the determination (including a summary of
the clinical or scientific evidence used in making the
determination);
(B) the procedures for obtaining additional information concerning the
determination; and
(C) notification of the right to an independent external review under
section 104 and instructions on how to initiate such a review.
SEC. 104. INDEPENDENT EXTERNAL APPEALS PROCEDURES.
(a) RIGHT TO EXTERNAL APPEAL- A group health plan, and a health insurance
issuer offering health insurance coverage, shall provide in accordance with
this section participants, beneficiaries, and enrollees (or authorized
representatives) with access to an independent external review for any denial
of a claim for benefits.
(b) INITIATION OF THE INDEPENDENT EXTERNAL REVIEW PROCESS-
(1) TIME TO FILE- A request for an independent external review under
this section shall be filed with the plan or issuer not later than 180 days
after the date on which the participant, beneficiary, or enrollee receives
notice of the denial under section 103(d) or notice of waiver of internal
review under section 103(a)(4) or the date on which the plan or issuer has
failed to make a timely decision under section 103(d)(2) and notifies the
participant or beneficiary that it has failed to make a timely decision and
that the beneficiary must file an appeal with an external review entity
within 180 days if the participant or beneficiary desires to file such an
appeal.
(A) IN GENERAL- Subject to the succeeding provisions of this
subsection, a group health plan, and a health insurance issuer offering
health insurance coverage, may--
(i) except as provided in subparagraph (B)(i), require that a
request for review be in writing;
(ii) limit the filing of such a request to the participant,
beneficiary, or enrollee involved (or an authorized
representative);
(iii) except if waived by the plan or issuer under section
103(a)(4), condition access to an independent external review under this
section upon a final determination of a denial of a claim for benefits
under the internal review procedure under section 103;
(iv) except as provided in subparagraph (B)(ii), require payment of
a filing fee to the plan or issuer of a sum that does not exceed $25;
and
(v) require that a request for review include the consent of the
participant, beneficiary, or enrollee (or authorized representative) for
the release of necessary medical information or records of the
participant, beneficiary, or enrollee to the qualified external review
entity only for purposes of conducting external review
activities.
(B) REQUIREMENTS AND EXCEPTION RELATING TO GENERAL RULE-
(i) ORAL REQUESTS PERMITTED IN EXPEDITED OR CONCURRENT CASES- In the
case of an expedited or concurrent external review as provided for under
subsection (e), the request may be made orally. A group health plan, or
health insurance issuer offering health insurance coverage, may require
that the participant,
beneficiary, or enrollee (or authorized representative) provide written
confirmation of such request in a timely manner on a form provided by the plan
or issuer. Such written confirmation shall be treated as a consent for purposes
of subparagraph (A)(v). In the case of such an oral request for such a review,
the making of the request (and the timing of such request) shall be treated as
the making at that time of a request for such an external review without regard
to whether and when a written confirmation of such request is made.
(ii) EXCEPTION TO FILING FEE REQUIREMENT-
(I) INDIGENCY- Payment of a filing fee shall not be required under
subparagraph (A)(iv) where there is a certification (in a form and
manner specified in guidelines established by the appropriate
Secretary) that the participant, beneficiary, or enrollee is indigent
(as defined in such guidelines).
(II) FEE NOT REQUIRED- Payment of a filing fee shall not be
required under subparagraph (A)(iv) if the plan or issuer waives the
internal appeals process under section 103(a)(4).
(III) REFUNDING OF FEE- The filing fee paid under subparagraph
(A)(iv) shall be refunded if the determination under the independent
external review is to reverse or modify the denial which is the
subject of the review.
(IV) COLLECTION OF FILING FEE- The failure to pay such a filing
fee shall not prevent the consideration of a request for review but,
subject to the preceding provisions of this clause, shall constitute a
legal liability to pay.
(c) REFERRAL TO QUALIFIED EXTERNAL REVIEW ENTITY UPON REQUEST-
(1) IN GENERAL- Upon the filing of a request for independent external
review with the group health plan, or health insurance issuer offering
health insurance coverage, the plan or issuer shall immediately refer such
request, and forward the plan or issuer's initial decision (including the
information described in section 103(d)(3)(A)), to a qualified external
review entity selected in accordance with this section.
(2) ACCESS TO PLAN OR ISSUER AND HEALTH PROFESSIONAL INFORMATION- With
respect to an independent external review conducted under this section, the
participant, beneficiary, or enrollee (or authorized representative), the
plan or issuer, and the treating health care professional (if any) shall
provide the external review entity with information that is necessary to
conduct a review under this section, as determined and requested by the
entity. Such information shall be provided not later than 5 days after the
date on which the request for information is received, or, in a case
described in clause (ii) or (iii) of subsection (e)(1)(A), by such earlier
time as may be necessary to comply with the applicable timeline under such
clause.
(3) SCREENING OF REQUESTS BY QUALIFIED EXTERNAL REVIEW ENTITIES-
(A) IN GENERAL- With respect to a request referred to a qualified
external review entity under paragraph (1) relating to a denial of a claim
for benefits, the entity shall refer such request for the conduct of an
independent medical review unless the entity determines that--
(i) any of the conditions described in clauses (ii) or (iii) of
subsection (b)(2)(A) have not been met;
(ii) the denial of the claim for benefits does not involve a
medically reviewable decision under subsection (d)(2);
(iii) the denial of the claim for benefits relates to a decision
regarding whether an individual is a participant, beneficiary, or
enrollee who is enrolled under the terms and conditions of the plan or
coverage (including the applicability of any waiting period under the
plan or coverage); or
(iv) the denial of the claim for benefits is a decision as to the
application of cost-sharing requirements or the application of a
specific exclusion or express limitation on the amount, duration, or
scope of coverage of items or services under the terms and conditions of
the plan or coverage unless the decision is a denial described in
subsection (d)(2).
Upon making a determination that any of clauses (i) through (iv)
applies with respect to the request, the entity shall determine that the
denial of a claim for benefits involved is not eligible for independent
medical review under subsection (d), and shall provide notice in
accordance with subparagraph (C).
(B) PROCESS FOR MAKING DETERMINATIONS-
(i) NO DEFERENCE TO PRIOR DETERMINATIONS- In making determinations
under subparagraph (A), there shall be no deference given to
determinations made by the plan or issuer or the recommendation of a
treating health care professional (if any).
(ii) USE OF APPROPRIATE PERSONNEL- A qualified external review
entity shall use appropriately qualified personnel to make
determinations under this section.
(C) NOTICES AND GENERAL TIMELINES FOR DETERMINATION-
(i) NOTICE IN CASE OF DENIAL OF REFERRAL- If the entity under this
paragraph does not make a referral to an independent medical reviewer,
the entity shall provide notice to the plan or issuer, the participant,
beneficiary, or enrollee (or authorized representative) filing the
request, and the treating health care professional (if any) that the
denial is not subject to independent medical review. Such
notice--
(I) shall be written (and, in addition, may be provided orally) in
a manner calculated to be understood by an average participant or
enrollee;
(II) shall include the reasons for the
determination;
(III) include any relevant terms and conditions of the plan or
coverage; and
(IV) include a description of any further recourse available to
the individual.
(ii) GENERAL TIMELINE FOR DETERMINATIONS- Upon receipt of
information under paragraph (2), the qualified external review entity,
and if required the independent medical reviewer, shall make a
determination within the overall timeline that is applicable to the case
under review as described in subsection (e), except that if the entity
determines that a referral to an independent medical reviewer is not
required, the entity shall provide notice of such determination to the
participant, beneficiary, or enrollee (or authorized representative)
within such timeline and within 2 days of the date of such
determination.
(d) INDEPENDENT MEDICAL REVIEW-
(1) IN GENERAL- If a qualified external review entity determines under
subsection (c) that a denial of a claim for benefits is eligible for
independent medical review, the entity shall refer the denial involved to an
independent medical reviewer for the conduct of an independent medical
review under this subsection.
(2) MEDICALLY REVIEWABLE DECISIONS- A denial of a claim for benefits is
eligible for independent medical review if the benefit for the item or
service for which the claim is made would be a covered benefit under the
terms and conditions of the plan or coverage but for one (or more) of the
following determinations:
(A) DENIALS BASED ON MEDICAL NECESSITY AND APPROPRIATENESS- A
determination that the item or service is not covered because it is not
medically necessary and appropriate or based on the application of
substantially equivalent terms.
(B) DENIALS BASED ON EXPERIMENTAL OR INVESTIGATIONAL TREATMENT- A
determination that the item or service is not covered because it is
experimental or investigational or based on the application of
substantially equivalent terms.
(C) DENIALS OTHERWISE BASED ON AN EVALUATION OF MEDICAL FACTS- A
determination that the item or service or condition is not covered based
on grounds that require an evaluation of the medical facts by a health
care professional in the specific case involved to determine the coverage
and extent of coverage of the item or service or condition.
(3) INDEPENDENT MEDICAL REVIEW DETERMINATION-
(A) IN GENERAL- An independent medical reviewer under this section
shall make a new independent determination with respect to whether or not
the denial of a claim for a benefit that is the subject of the review
should be upheld, reversed, or modified.
(B) STANDARD FOR DETERMINATION- The independent medical reviewer's
determination relating to the medical necessity and appropriateness, or
the experimental or investigation nature, or the evaluation of the medical
facts of the item, service, or condition shall be based on the medical
condition of the participant, beneficiary, or enrollee (including the
medical records of the participant, beneficiary, or enrollee) and valid,
relevant scientific evidence and clinical evidence, including
peer-reviewed medical literature or findings and including expert
opinion.
(C) NO COVERAGE FOR EXCLUDED BENEFITS- Nothing in this subsection
shall be construed to permit an independent medical reviewer to require
that a group health plan, or health insurance issuer offering health
insurance coverage, provide coverage for items or
services for which benefits are specifically excluded or expressly limited
under the plan or coverage in the plain language of the plan document (and which
are disclosed under section 121(b)(1)(C)) except to the extent that the
application or interpretation of the exclusion or limitation involves a
determination described in paragraph (2).
(D) EVIDENCE AND INFORMATION TO BE USED IN MEDICAL REVIEWS- In making
a determination under this subsection, the independent medical reviewer
shall also consider appropriate and available evidence and information,
including the following:
(i) The determination made by the plan or issuer with respect to the
claim upon internal review and the evidence, guidelines, or rationale
used by the plan or issuer in reaching such determination.
(ii) The recommendation of the treating health care professional and
the evidence, guidelines, and rationale used by the treating health care
professional in reaching such recommendation.
(iii) Additional relevant evidence or information obtained by the
reviewer or submitted by the plan, issuer, participant, beneficiary, or
enrollee (or an authorized representative), or treating health care
professional.
(iv) The plan or coverage document.
(E) INDEPENDENT DETERMINATION- In making determinations under this
subtitle, a qualified external review entity and an independent medical
reviewer shall--
(i) consider the claim under review without deference to the
determinations made by the plan or issuer or the recommendation of the
treating health care professional (if any); and
(ii) consider, but not be bound by the definition used by the plan
or issuer of `medically necessary and appropriate', or `experimental or
investigational', or other substantially equivalent terms that are used
by the plan or issuer to describe medical necessity and appropriateness
or experimental or investigational nature of the treatment.
(F) DETERMINATION OF INDEPENDENT MEDICAL REVIEWER- An independent
medical reviewer shall, in accordance with the deadlines described in
subsection (e), prepare a written determination to uphold, reverse, or
modify the denial under review. Such written determination shall
include--
(i) the determination of the reviewer;
(ii) the specific reasons of the reviewer for such determination,
including a summary of the clinical or scientific evidence used in
making the determination; and
(iii) with respect to a determination to reverse or modify the
denial under review, a timeframe within which the plan or issuer must
comply with such determination.
(G) NONBINDING NATURE OF ADDITIONAL RECOMMENDATIONS- In addition to
the determination under subparagraph (F), the reviewer may provide the
plan or issuer and the treating health care professional with additional
recommendations in connection with such a determination, but any such
recommendations shall not affect (or be treated as part of) the
determination and shall not be binding on the plan or issuer.
(e) TIMELINES AND NOTIFICATIONS-
(1) TIMELINES FOR INDEPENDENT MEDICAL REVIEW-
(A) PRIOR AUTHORIZATION DETERMINATION-
(i) IN GENERAL- The independent medical reviewer (or reviewers)
shall make a determination on a denial of a claim for benefits that is
referred to the reviewer under subsection (c)(3) in accordance with the
medical exigencies of the case and as soon as possible, but in no case
later than 14 days after the date of receipt of information under
subsection (c)(2) if the review involves a prior authorization of items
or services and in no case later than 21 days after the date the request
for external review is received.
(ii) EXPEDITED DETERMINATION- Notwithstanding clause (i) and subject
to clause (iii), the independent medical reviewer (or reviewers) shall
make an expedited determination on a denial of a claim for benefits
described in clause (i), when a request for such an expedited
determination is made by a participant, beneficiary, or enrollee (or
authorized representative) at any time during the process for making a
determination, and a health care professional certifies, with the
request, that a determination under the timeline described in clause (i)
would seriously jeopardize the life or health of the participant,
beneficiary, or enrollee or the ability of the participant, beneficiary,
or enrollee to maintain or regain maximum function. Such determination
shall be made as soon in accordance with the medical exigencies of the
case and as soon as possible, but in no case later than 72 hours after
the time the request for external review is received by the qualified
external review entity.
(iii) ONGOING CARE DETERMINATION- Notwithstanding clause (i), in the
case of a review described in such subclause that involves a termination
or reduction of care, the notice of the determination shall be completed
not later than 24 hours after the time the request for external review
is received by the qualified external review entity and before the end
of the approved period of care.
(B) RETROSPECTIVE DETERMINATION- The independent medical reviewer (or
reviewers) shall complete a review in the case of a retrospective
determination on an appeal of a denial of a claim for benefits that is
referred to the reviewer under subsection (c)(3) in no case later than 30
days after the date of receipt of information under subsection (c)(2) and
in no case later than 60 days after the date the request for external
review is received by the qualified external review entity.
(2) NOTIFICATION OF DETERMINATION- The external review entity shall
ensure that the plan or issuer, the participant, beneficiary, or enrollee
(or authorized representative) and the treating health care professional (if
any) receives a copy of the written determination of the independent medical
reviewer prepared under subsection (d)(3)(F). Nothing in this paragraph
shall be construed as preventing
an entity or reviewer from providing an initial oral notice of the reviewer's
determination.
(3) FORM OF NOTICES- Determinations and notices under this subsection
shall be written in a manner calculated to be understood by an average
participant.
(1) APPLICATION OF DETERMINATIONS-
(A) EXTERNAL REVIEW DETERMINATIONS BINDING ON PLAN- The determinations
of an external review entity and an independent medical reviewer under
this section shall be binding upon the plan or issuer involved.
(B) COMPLIANCE WITH DETERMINATION- If the determination of an
independent medical reviewer is to reverse or modify the denial, the plan
or issuer, upon the receipt of such determination, shall authorize
coverage to comply with the medical reviewer's determination in accordance
with the timeframe established by the medical reviewer.
(A) IN GENERAL- If a plan or issuer fails to comply with the timeframe
established under paragraph (1)(B) with respect to a participant,
beneficiary, or enrollee, where such failure to comply is caused by the
plan or issuer, the participant, beneficiary, or enrollee may obtain the
items or services involved (in a manner consistent with the determination
of the independent external reviewer) from any provider regardless of
whether such provider is a participating provider under the plan or
coverage.
(i) IN GENERAL- Where a participant, beneficiary, or enrollee
obtains items or services in accordance with subparagraph (A), the plan
or issuer involved shall provide for reimbursement of the costs of such
items or services. Such reimbursement shall be made to the treating
health care professional or to the participant, beneficiary, or enrollee
(in the case of a participant, beneficiary, or enrollee who pays for the
costs of such items or services).
(ii) AMOUNT- The plan or issuer shall fully reimburse a
professional, participant, beneficiary, or enrollee under clause (i) for
the total costs of the items or services provided (regardless of any
plan limitations that may apply to the coverage of such items or
services) so long as the items or services were provided in a manner
consistent with the determination of the independent medical
reviewer.
(C) FAILURE TO REIMBURSE- Where a plan or issuer fails to provide
reimbursement to a professional, participant, beneficiary, or enrollee in
accordance with this paragraph, the professional, participant,
beneficiary, or enrollee may commence a civil action (or utilize other
remedies available under law) to recover only the amount of any such
reimbursement that is owed by the plan or issuer and any necessary legal
costs or expenses (including attorney's fees) incurred in recovering such
reimbursement.
(D) AVAILABLE REMEDIES- The remedies provided under this paragraph are
in addition to any other available remedies.
(3) PENALTIES AGAINST AUTHORIZED OFFICIALS FOR REFUSING TO AUTHORIZE THE
DETERMINATION OF AN EXTERNAL REVIEW ENTITY-
(i) IN GENERAL- In any case in which the determination of an
external review entity is not followed by a group health plan, or by a
health insurance issuer offering health insurance coverage, any person
who, acting in the capacity of authorizing the benefit, causes such
refusal may, in the discretion in a court of competent jurisdiction, be
liable to an aggrieved participant, beneficiary, or enrollee for a civil
penalty in an amount of up to $1,000 a day from the date on which the
determination was transmitted to the plan or issuer by the external
review entity until the date the refusal to provide the benefit is
corrected.
(ii) ADDITIONAL PENALTY FOR FAILING TO FOLLOW TIMELINE- In any case
in which treatment was not commenced by the plan in accordance with the
determination of an independent external reviewer, the Secretary shall
assess a civil penalty of $10,000 against the plan and the plan shall
pay such penalty to the participant, beneficiary, or enrollee
involved.
(B) CEASE AND DESIST ORDER AND ORDER OF ATTORNEY'S FEES- In any action
described in subparagraph (A) brought by a participant, beneficiary, or
enrollee with respect to a group health plan, or a health insurance issuer
offering health insurance coverage, in which a plaintiff alleges that a
person referred to in such subparagraph has taken an action resulting in a
refusal of a benefit determined by an external appeal entity to be
covered, or has failed to take an action for which such person is
responsible under the terms and conditions of the plan or coverage and
which is necessary under the plan or coverage for authorizing a benefit,
the court shall cause to be served on the defendant an order requiring the
defendant--
(i) to cease and desist from the alleged action or failure to act;
and
(ii) to pay to the plaintiff a reasonable attorney's fee and other
reasonable costs relating to the prosecution of the action on the
charges on which the plaintiff prevails.
(C) ADDITIONAL CIVIL PENALTIES-
(i) IN GENERAL- In addition to any penalty imposed under
subparagraph (A) or (B), the appropriate Secretary may assess a civil
penalty against a person acting in the capacity of authorizing a benefit
determined by an external review entity for one or more group health
plans, or health insurance issuers offering health insurance coverage,
for--
(I) any pattern or practice of repeated refusal to authorize a
benefit determined by an external appeal entity to be covered;
or
(II) any pattern or practice of repeated violations of the
requirements of this section with respect to such plan or
coverage.
(ii) STANDARD OF PROOF AND AMOUNT OF PENALTY- Such penalty shall be
payable only upon proof by clear and convincing evidence of such pattern
or practice and shall be in an amount not to exceed the lesser
of--
(I) 25 percent of the aggregate value of benefits shown by the
appropriate Secretary to have not been provided, or unlawfully
delayed, in violation of this section under such pattern or practice;
or
(D) REMOVAL AND DISQUALIFICATION- Any person acting in the capacity of
authorizing benefits who has engaged in any such pattern or practice
described in subparagraph (C)(i) with respect to a plan or coverage, upon
the petition of the appropriate Secretary, may be removed by the court
from such position, and from any other involvement, with respect to such a
plan or coverage, and may be precluded from returning to any such position
or involvement for a period determined by the court.
(4) PROTECTION OF LEGAL RIGHTS- Nothing in this subsection or subtitle
shall be construed as altering or eliminating any cause of action or legal
rights or remedies of participants, beneficiaries, enrollees, and others
under State or Federal law (including sections 502 and 503 of the Employee
Retirement Income Security Act of 1974), including the right to file
judicial actions to enforce rights.
(g) QUALIFICATIONS OF INDEPENDENT MEDICAL REVIEWERS-
(1) IN GENERAL- In referring a denial to 1 or more individuals to
conduct independent medical review under subsection (c), the qualified
external review entity shall ensure that--
(A) each independent medical reviewer meets the qualifications
described in paragraphs (2) and (3);
(B) with respect to each review at least 1 such reviewer meets the
requirements described in paragraphs (4) and (5); and
(C) compensation provided by the entity to the reviewer is consistent
with paragraph (6).
(2) LICENSURE AND EXPERTISE- Each independent medical reviewer shall be
a physician (allopathic or osteopathic) or health care professional
who--
(A) is appropriately credentialed or licensed in 1 or more States to
deliver health care services; and
(B) typically treats the condition, makes the diagnosis, or provides
the type of treatment under review.
(A) IN GENERAL- Subject to subparagraph (B), each independent medical
reviewer in a case shall--
(i) not be a related party (as defined in paragraph
(7));
(ii) not have a material familial, financial, or professional
relationship with such a party; and
(iii) not otherwise have a conflict of interest with such a party
(as determined under regulations).
(B) EXCEPTION- Nothing in subparagraph (A) shall be construed
to--
(i) prohibit an individual, solely on the basis of affiliation with
the plan or issuer, from serving as an independent medical reviewer
if--
(I) a non-affiliated individual is not reasonably
available;
(II) the affiliated individual is not involved in the provision of
items or services in the case under review;
(III) the fact of such an affiliation is disclosed to the plan or
issuer and the participant, beneficiary, or enrollee (or authorized
representative) and neither party objects; and
(IV) the affiliated individual is not an employee of the plan or
issuer and does not provide services exclusively or primarily to or on
behalf of the plan or issuer;
(ii) prohibit an individual who has staff privileges at the
institution where the treatment involved takes place from serving as an
independent medical reviewer merely on the basis of such affiliation if
the affiliation is disclosed to the plan or issuer and the participant,
beneficiary, or enrollee (or authorized representative), and neither
party objects; or
(iii) prohibit receipt of compensation by an independent medical
reviewer from an entity if the compensation is provided consistent with
paragraph (6).
(4) PRACTICING HEALTH CARE PROFESSIONAL IN SAME FIELD-
(A) IN GENERAL- In a case involving treatment, or the provision of
items or services--
(i) by a physician, a reviewer shall be a practicing physician
(allopathic or osteopathic) of the same or similar specialty, as a
physician who typically treats the condition, makes the diagnosis, or
provides the type of treatment under review; or
(ii) by a health care professional (other than a physician), a
reviewer shall be a practicing physician (allopathic or osteopathic) or,
if determined appropriate by the qualified external review entity, a
practicing health care professional (other than such a physician), of
the same or similar specialty as the health care professional who
typically treats the condition, makes the diagnosis, or provides the
type of treatment under review.
(B) PRACTICING DEFINED- For purposes of this paragraph, the term
`practicing' means, with respect to an individual who is a physician or
other health care professional that the individual provides health care
services to individual patients on average at least 2 days per
week.
(5) PEDIATRIC EXPERTISE- In the case of an external review relating to a
child, a reviewer shall have expertise under paragraph (2) in
pediatrics.
(6) LIMITATIONS ON REVIEWER COMPENSATION- Compensation provided by a
qualified external review entity to an independent medical reviewer in
connection with a review under this section shall--
(A) not exceed a reasonable level; and
(B) not be contingent on the decision rendered by the
reviewer.
(7) RELATED PARTY DEFINED- For purposes of this section, the term
`related party' means, with respect to a denial of a claim under a plan or
coverage relating to a participant, beneficiary, or enrollee, any of the
following:
(A) The plan, plan sponsor, or issuer involved, or any fiduciary,
officer, director, or employee of such plan, plan sponsor, or
issuer.
(B) The participant, beneficiary, or enrollee (or authorized
representative).
(C) The health care professional that provides the items or services
involved in the denial.
(D) The institution at which the items or services (or treatment)
involved in the denial are provided.
(E) The manufacturer of any drug or other item that is included in the
items or services involved in the denial.
(F) Any other party determined under any regulations to have a
substantial interest in the denial involved.
(h) QUALIFIED EXTERNAL REVIEW ENTITIES-
(1) SELECTION OF QUALIFIED EXTERNAL REVIEW ENTITIES-
(A) LIMITATION ON PLAN OR ISSUER SELECTION- The appropriate Secretary
shall implement procedures--
(i) to assure that the selection process among qualified external
review entities will not create any incentives for external review
entities to make a decision in a biased manner; and
(ii) for auditing a sample of decisions by such entities to assure
that no such decisions are made in a biased manner.
No such selection process under the procedures implemented by the
appropriate Secretary may give either the patient or the plan or issuer
any ability to determine or influence the selection of a qualified
external review entity to review the case of any participant, beneficiary,
or enrollee.
(B) STATE AUTHORITY WITH RESPECT TO QUALIFIED EXTERNAL REVIEW ENTITIES
FOR HEALTH INSURANCE ISSUERS- With respect to health insurance issuers
offering health insurance coverage in a State, the State may provide for
external review activities to be conducted by a qualified external appeal
entity that is designated by the State or that is selected by the State in
a manner determined by the State to assure an unbiased
determination.
(2) CONTRACT WITH QUALIFIED EXTERNAL REVIEW ENTITY- Except as provided
in paragraph (1)(B), the external review process of a plan or issuer under
this section shall be conducted under a contract between the plan or issuer
and 1 or more qualified external review entities (as defined in paragraph
(4)(A)).
(3) TERMS AND CONDITIONS OF CONTRACT- The terms and conditions of a
contract under paragraph (2) shall--
(A) be consistent with the standards the appropriate Secretary shall
establish to assure there is no real or apparent conflict of interest in
the conduct of external review activities; and
(B) provide that the costs of the external review process shall be
borne by the plan or issuer.
Subparagraph (B) shall not be construed as applying to the imposition of
a filing fee under subsection (b)(2)(A)(iv) or costs incurred by the
participant, beneficiary, or enrollee (or authorized representative) or
treating health care professional (if any) in support of the review,
including the provision of additional evidence or information.
(A) IN GENERAL- In this section, the term `qualified external review
entity' means, in relation to a plan or issuer, an entity that is
initially certified (and periodically recertified) under subparagraph (C)
as meeting the following requirements:
(i) The entity has (directly or through contracts or other
arrangements) sufficient medical, legal, and other expertise and
sufficient staffing to carry out duties of a
qualified external review entity under this section on a timely basis,
including making determinations under subsection (b)(2)(A) and providing for
independent medical reviews under subsection (d).
(ii) The entity is not a plan or issuer or an affiliate or a
subsidiary of a plan or issuer, and is not an affiliate or subsidiary of
a professional or trade association of plans or issuers or of health
care providers.
(iii) The entity has provided assurances that it will conduct
external review activities consistent with the applicable requirements
of this section and standards specified in subparagraph (C), including
that it will not conduct any external review activities in a case unless
the independence requirements of subparagraph (B) are met with respect
to the case.
(iv) The entity has provided assurances that it will provide
information in a timely manner under subparagraph (D).
(v) The entity meets such other requirements as the appropriate
Secretary provides by regulation.
(B) INDEPENDENCE REQUIREMENTS-
(i) IN GENERAL- Subject to clause (ii), an entity meets the
independence requirements of this subparagraph with respect to any case
if the entity--
(I) is not a related party (as defined in subsection
(g)(7));
(II) does not have a material familial, financial, or professional
relationship with such a party; and
(III) does not otherwise have a conflict of interest with such a
party (as determined under regulations).
(ii) EXCEPTION FOR REASONABLE COMPENSATION- Nothing in clause (i)
shall be construed to prohibit receipt by a qualified external review
entity of compensation from a plan or issuer for the conduct of external
review activities under this section if the compensation is provided
consistent with clause (iii).
(iii) LIMITATIONS ON ENTITY COMPENSATION- Compensation provided by a
plan or issuer to a qualified external review entity in connection with
reviews under this section shall--
(I) not exceed a reasonable level; and
(II) not be contingent on any decision rendered by the entity or
by any independent medical reviewer.
(C) CERTIFICATION AND RECERTIFICATION PROCESS-
(i) IN GENERAL- The initial certification and recertification of a
qualified external review entity shall be made--
(I) under a process that is recognized or approved by the
appropriate Secretary; or
(II) by a qualified private standard-setting organization that is
approved by the appropriate Secretary under clause
(iii).
In taking action under subclause (I), the appropriate Secretary
shall give deference to entities that are under contract with the
Federal Government or with an applicable State authority to perform
functions of the type performed by qualified external review
entities.
(ii) PROCESS- The appropriate Secretary shall not recognize or
approve a process under clause (i)(I) unless the process applies
standards (as promulgated in regulations) that ensure that a qualified
external review entity--
(I) will carry out (and has carried out, in the case of
recertification) the responsibilities of such an entity in accordance
with this section, including meeting applicable
deadlines;
(II) will meet (and has met, in the case of recertification)
appropriate indicators of fiscal integrity;
(III) will maintain (and has maintained, in the case of
recertification) appropriate confidentiality with respect to
individually identifiable health information obtained in the course of
conducting external review activities; and
(IV) in the case recertification, shall review the matters
described in clause (iv).
(iii) APPROVAL OF QUALIFIED PRIVATE STANDARD-SETTING ORGANIZATIONS-
For purposes of clause (i)(II), the appropriate Secretary may approve a
qualified private standard-setting organization if such Secretary finds
that the organization only certifies (or recertifies) external review
entities that meet at least the standards required for the certification
(or recertification) of external review entities under clause
(ii).
(iv) CONSIDERATIONS IN RECERTIFICATIONS- In conducting
recertifications of a qualified external review entity under this
paragraph, the appropriate Secretary or organization conducting the
recertification shall review compliance of the entity with the
requirements for conducting external review activities under this
section, including the following:
(I) Provision of information under subparagraph
(D).
(II) Adherence to applicable deadlines (both by the entity and by
independent medical reviewers it refers cases to).
(III) Compliance with limitations on compensation (with respect to
both the entity and independent medical reviewers it refers cases
to).
(IV) Compliance with applicable independence
requirements.
(v) PERIOD OF CERTIFICATION OR RECERTIFICATION- A certification or
recertification provided under this paragraph shall extend for a period
not to exceed 2 years.
(vi) REVOCATION- A certification or recertification under this
paragraph may be revoked by the appropriate Secretary or by the
organization providing such certification upon a showing of
cause.
(vii) SUFFICIENT NUMBER OF ENTITIES- The appropriate Secretary shall
certify and recertify a number of external review entities which is
sufficient to ensure
the timely and efficient provision of review services.
(D) PROVISION OF INFORMATION-
(i) IN GENERAL- A qualified external review entity shall provide to
the appropriate Secretary, in such manner and at such times as such
Secretary may require, such information (relating to the denials which
have been referred to the entity for the conduct of external review
under this section) as such Secretary determines appropriate to assure
compliance with the independence and other requirements of this section
to monitor and assess the quality of its external review activities and
lack of bias in making determinations. Such information shall include
information described in clause (ii) but shall not include individually
identifiable medical information.
(ii) INFORMATION TO BE INCLUDED- The information described in this
subclause with respect to an entity is as follows:
(I) The number and types of denials for which a request for review
has been received by the entity.
(II) The disposition by the entity of such denials, including the
number referred to a independent medical reviewer and the reasons for
such dispositions (including the application of exclusions), on a plan
or issuer-specific basis and on a health care specialty-specific
basis.
(III) The length of time in making determinations with respect to
such denials.
(IV) Updated information on the information required to be
submitted as a condition of certification with respect to the entity's
performance of external review activities.
(iii) INFORMATION TO BE PROVIDED TO CERTIFYING
ORGANIZATION-
(I) IN GENERAL- In the case of a qualified external review entity
which is certified (or recertified) under this subsection by a
qualified private standard-setting organization, at the request of the
organization, the entity shall provide the organization with the
information provided to the appropriate Secretary under clause
(i).
(II) ADDITIONAL INFORMATION- Nothing in this subparagraph shall be
construed as preventing such an organization from requiring additional
information as a condition of certification or recertification of an
entity.
(iv) USE OF INFORMATION- Information provided under this
subparagraph may be used by the appropriate Secretary and qualified
private standard-setting organizations to conduct oversight of qualified
external review entities, including recertification of such entities,
and shall be made available to the public in an appropriate
manner.
(E) LIMITATION ON LIABILITY- No qualified external review entity
having a contract with a plan or issuer, and no person who is employed by
any such entity or who furnishes professional services to such entity
(including as an independent medical reviewer), shall be held by reason of
the performance of any duty, function, or activity required or authorized
pursuant to this section, to be civilly liable under any law of the United
States or of any State (or political subdivision thereof) if there was no
actual malice or gross misconduct in the performance of such duty,
function, or activity.
Subtitle B--Access to Care
SEC. 111. CONSUMER CHOICE OPTION.
(1) a health insurance issuer providing health insurance coverage in
connection with a group health plan offers to enrollees health insurance
coverage which provides for coverage of services only if such services are
furnished through health care professionals and providers who are members of
a network of health care professionals and providers who have entered into a
contract with the issuer to provide such services, or
(2) a group health plan offers to participants or beneficiaries health
benefits which provide for coverage of services only if such services are
furnished through health care professionals and providers who are members of
a network of health care professionals and providers who have entered into a
contract with the plan to provide such services,
then the issuer or plan shall also offer or arrange to be offered to such
enrollees, participants, or beneficiaries (at the time of enrollment and
during an annual open season as provided under subsection (c)) the option of
health insurance coverage or health benefits which provide for coverage of
such services which are not furnished through health care professionals and
providers who are members of such a network unless such enrollees,
participants, or beneficiaries are offered such non-network coverage through
another group health plan or through another health insurance issuer in the
group market.
(b) ADDITIONAL COSTS- The amount of any additional premium charged by the
health insurance issuer or group health plan for the additional cost of the
creation and maintenance of the option described in subsection (a) and the
amount of any additional cost sharing imposed under such option shall be borne
by the enrollee, participant, or beneficiary unless it is paid by the health
plan sponsor or group health plan through agreement with the health insurance
issuer.
(c) OPEN SEASON- An enrollee, participant, or beneficiary, may change to
the offering provided under this section only during a time period determined
by the health insurance issuer or group health plan. Such time period shall
occur at least annually.
SEC. 112. CHOICE OF HEALTH CARE PROFESSIONAL.
(a) PRIMARY CARE- If a group health plan, or a health insurance issuer
that offers health insurance coverage, requires or provides for designation by
a participant, beneficiary, or enrollee of a participating primary care
provider, then the plan or issuer shall permit each participant, beneficiary,
and enrollee to designate any participating primary care provider who is
available to accept such individual.
(1) IN GENERAL- Subject to paragraph (2), a group health plan and a
health insurance issuer that offers health insurance coverage shall permit
each participant, beneficiary, or enrollee to receive medically necessary
and appropriate specialty care, pursuant to appropriate referral procedures,
from any qualified participating health care professional who is available
to accept such individual for such care.
(2) LIMITATION- Paragraph (1) shall not apply to specialty care if the
plan or issuer clearly informs participants, beneficiaries, and enrollees of
the limitations on choice of participating health care professionals with
respect to such care.
(3) CONSTRUCTION- Nothing in this subsection shall be construed as
affecting the application of section 114 (relating to access to specialty
care).
SEC. 113. ACCESS TO EMERGENCY CARE.
(a) COVERAGE OF EMERGENCY SERVICES-
(1) IN GENERAL- If a group health plan, or health insurance coverage
offered by a health insurance issuer, provides or covers any benefits with
respect to services in an emergency department of a hospital, the plan or
issuer shall cover emergency services (as defined in paragraph
(2)(B))--
(A) without the need for any prior authorization
determination;
(B) whether the health care provider furnishing such services is a
participating provider with respect to such services;
(C) in a manner so that, if such services are provided to a
participant, beneficiary, or enrollee--
(i) by a nonparticipating health care provider with or without prior
authorization, or
(ii) by a participating health care provider without prior
authorization,
the participant, beneficiary, or enrollee is not liable for amounts
that exceed the amounts of liability that would be incurred if the
services were provided by a participating health care provider with prior
authorization; and
(D) without regard to any other term or condition of such coverage
(other than exclusion or coordination of benefits, or an affiliation or
waiting period, permitted under section 2701 of the Public Health Service
Act, section 701 of the Employee Retirement Income Security Act of 1974,
or section 9801 of the Internal Revenue Code of 1986, and other than
applicable cost-sharing).
(2) DEFINITIONS- In this section:
(A) EMERGENCY MEDICAL CONDITION- The term `emergency medical
condition' means a medical condition manifesting itself by acute symptoms
of sufficient severity (including severe pain) such that a prudent
layperson, who possesses an average knowledge of health and medicine,
could reasonably expect the absence of immediate medical attention to
result in a condition described in clause (i), (ii), or (iii) of section
1867(e)(1)(A) of the Social Security Act.
(B) EMERGENCY SERVICES- The term `emergency services' means, with
respect to an emergency medical condition--
(i) a medical screening examination (as required under section 1867
of the Social Security Act) that is within the capability of the
emergency department of a hospital, including ancillary services
routinely available to the emergency department to evaluate such
emergency medical condition, and
(ii) within the capabilities of the staff and facilities available
at the hospital, such further medical examination and treatment as are
required under section 1867 of such Act to stabilize the
patient.
(C) STABILIZE- The term `to stabilize', with respect to an emergency
medical condition (as defined in subparagraph (A)), has the meaning give
in section 1867(e)(3) of the Social Security Act (42 U.S.C.
1395dd(e)(3)).
(b) REIMBURSEMENT FOR MAINTENANCE CARE AND POST-STABILIZATION CARE- A
group health plan, and health insurance coverage offered by a health insurance
issuer, must provide reimbursement for maintenance care and post-stabilization
care in accordance with the requirements of section 1852(d)(2) of the Social
Security Act (42 U.S.C. 1395w-22(d)(2)). Such reimbursement shall be provided
in a manner consistent with subsection (a)(1)(C).
(c) COVERAGE OF EMERGENCY AMBULANCE SERVICES-
(1) IN GENERAL- If a group health plan, or health insurance coverage
provided by a health insurance issuer, provides any benefits with respect to
ambulance services and emergency services, the plan or issuer shall cover
emergency ambulance services (as defined in paragraph (2)) furnished under
the plan or coverage under the same terms and conditions under subparagraphs
(A) through (D) of subsection (a)(1) under which coverage is provided for
emergency services.
(2) EMERGENCY AMBULANCE SERVICES- For purposes of this subsection, the
term `emergency ambulance services' means ambulance services (as
defined for purposes of section 1861(s)(7) of the Social Security Act)
furnished to transport an individual who has an emergency medical condition (as
defined in subsection (a)(2)(A)) to a hospital for the receipt of emergency
services (as defined in subsection (a)(2)(B)) in a case in which the emergency
services are covered under the plan or coverage pursuant to subsection (a)(1)
and a prudent layperson, with an average knowledge of health and medicine, could
reasonably expect that the absence of such transport would result in placing the
health of the individual in serious jeopardy, serious impairment of bodily
function, or serious dysfunction of any bodily organ or part.
SEC. 114. TIMELY ACCESS TO SPECIALISTS.
(1) IN GENERAL- A group health plan or health insurance issuer offering
health insurance coverage shall ensure that participants, beneficiaries, and
enrollees receive timely access to specialists who are appropriate to the
condition of, and accessible to, the participant, beneficiary, or enrollee,
when such specialty care is a covered benefit under the plan or
coverage.
(2) RULE OF CONSTRUCTION- Nothing in paragraph (1) shall be
construed--
(A) to require the coverage under a group health plan or health
insurance coverage of benefits or services;
(B) to prohibit a plan or issuer from including providers in the
network only to the extent necessary to meet the needs of the plan's or
issuer's participants, beneficiaries, or enrollees; or
(C) to override any State licensure or scope-of-practice law.
(3) ACCESS TO CERTAIN PROVIDERS-
(A) IN GENERAL- With respect to specialty care under this section, if
a participating specialist is not available and qualified to provide such
care to the participant, beneficiary, or enrollee, the plan or issuer
shall provide for coverage of such care by a nonparticipating
specialist.
(B) TREATMENT OF NONPARTICIPATING PROVIDERS- If a participant,
beneficiary, or enrollee receives care from a nonparticipating specialist
pursuant to subparagraph (A), such specialty care shall be provided at no
additional cost to the participant, beneficiary, or enrollee beyond what
the participant, beneficiary, or enrollee would otherwise pay for such
specialty care if provided by a participating specialist.
(1) AUTHORIZATION- A group health plan or health insurance issuer may
require an authorization in order to obtain coverage for specialty services
under this section. Any such authorization--
(A) shall be for an appropriate duration of time or number of
referrals; and
(B) may not be refused solely because the authorization involves
services of a nonparticipating specialist (described in subsection
(a)(3)).
(2) REFERRALS FOR ONGOING SPECIAL CONDITIONS-
(A) IN GENERAL- A group health plan or health insurance issuer shall
permit a participant, beneficiary, or enrollee who has an ongoing special
condition (as defined in subparagraph (B)) to receive a referral to a
specialist for the treatment of such condition and such specialist may
authorize such referrals, procedures, tests, and other medical services
with respect to such condition, or coordinate the care for such condition,
subject to the terms of a treatment plan (if any) referred to in
subsection (c) with respect to the condition.
(B) ONGOING SPECIAL CONDITION DEFINED- In this subsection, the term
`ongoing special condition' means a condition or disease that--
(i) is life-threatening, degenerative, potentially disabling, or
congenital; and
(ii) requires specialized medical care over a prolonged period of
time.
(1) IN GENERAL- A group health plan or health insurance issuer may
require that the specialty care be provided--
(A) pursuant to a treatment plan, but only if the treatment
plan--
(i) is developed by the specialist, in consultation with the case
manager or primary care provider, and the participant, beneficiary, or
enrollee, and
(ii) is approved by the plan or issuer in a timely manner, if the
plan or issuer requires such approval; and
(B) in accordance with applicable quality assurance and utilization
review standards of the plan or issuer.
(2) NOTIFICATION- Nothing in paragraph (1) shall be construed as
prohibiting a plan or issuer from requiring the specialist to provide the
plan or issuer with regular updates on the specialty care provided, as well
as all other reasonably necessary medical information.
(d) SPECIALIST DEFINED- For purposes of this section, the term
`specialist' means, with respect to the condition of the participant,
beneficiary, or enrollee, a health care professional, facility, or center that
has adequate expertise through appropriate training and experience (including,
in the case of a child, appropriate pediatric expertise) to provide high
quality care in treating the condition.
SEC. 115. PATIENT ACCESS TO OBSTETRIC AND GYNECOLOGICAL CARE.
(1) DIRECT ACCESS- A group health plan, or health insurance issuer
offering health insurance coverage, described in subsection (b) may not
require authorization or referral by the plan, issuer, or any person
(including a primary care provider described in subsection (b)(2)) in the
case of a female
participant, beneficiary, or enrollee who seeks coverage for obstetrical or
gynecological care provided by a participating health care professional who
specializes in obstetrics or gynecology.
(2) OBSTETRICAL AND GYNECOLOGICAL CARE- A group health plan or health
insurance issuer described in subsection (b) shall treat the provision of
obstetrical and gynecological care, and the ordering of related obstetrical
and gynecological items and services, pursuant to the direct access
described under paragraph (1), by a participating health care professional
who specializes in obstetrics or gynecology as the authorization of the
primary care provider.
(b) APPLICATION OF SECTION- A group health plan, or health insurance
issuer offering health insurance coverage, described in this subsection is a
group health plan or coverage that--
(1) provides coverage for obstetric or gynecologic care; and
(2) requires the designation by a participant, beneficiary, or enrollee
of a participating primary care provider.
(c) CONSTRUCTION- Nothing in subsection (a) shall be construed to--
(1) waive any exclusions of coverage under the terms and conditions of
the plan or health insurance coverage with respect to coverage of
obstetrical or gynecological care; or
(2) preclude the group health plan or health insurance issuer involved
from requiring that the obstetrical or gynecological provider notify the
primary care health care professional or the plan or issuer of treatment
decisions.
SEC. 116. ACCESS TO PEDIATRIC CARE.
(a) PEDIATRIC CARE- In the case of a person who has a child who is a
participant, beneficiary, or enrollee under a group health plan, or health
insurance coverage offered by a health insurance issuer, if the plan or issuer
requires or provides for the designation of a participating primary care
provider for the child, the plan or issuer shall permit such person to
designate a physician (allopathic or osteopathic) who specializes in
pediatrics as the child's primary care provider if such provider participates
in the network of the plan or issuer.
(b) CONSTRUCTION- Nothing in subsection (a) shall be construed to waive
any exclusions of coverage under the terms and conditions of the plan or
health insurance coverage with respect to coverage of pediatric care.
SEC. 117. CONTINUITY OF CARE.
(a) TERMINATION OF PROVIDER-
(A) a contract between a group health plan, or a health insurance
issuer offering health insurance coverage, and a treating health care
provider is terminated (as defined in paragraph (e)(4)), or
(B) benefits or coverage provided by a health care provider are
terminated because of a change in the terms of provider participation in
such plan or coverage,
the plan or issuer shall meet the requirements of paragraph (3) with
respect to each continuing care patient.
(2) TREATMENT OF TERMINATION OF CONTRACT WITH HEALTH INSURANCE ISSUER-
If a contract for the provision of health insurance coverage between a group
health plan and a health insurance issuer is terminated and, as a result of
such termination, coverage of services of a health care provider is
terminated with respect to an individual, the provisions of paragraph (1)
(and the succeeding provisions of this section) shall apply under the plan
in the same manner as if there had been a contract between the plan and the
provider that had been terminated, but only with respect to benefits that
are covered under the plan after the contract termination.
(3) REQUIREMENTS- The requirements of this paragraph are that the plan
or issuer--
(A) notify the continuing care patient involved, or arrange to have
the patient notified pursuant to subsection (d)(2), on a timely basis of
the termination described in paragraph (1) (or paragraph (2), if
applicable) and the right to elect continued transitional care from the
provider under this section;
(B) provide the patient with an opportunity to notify the plan or
issuer of the patient's need for transitional care; and
(C) subject to subsection (c), permit the patient to elect to continue
to be covered with respect to the course of treatment by such provider
with the provider's consent during a transitional period (as provided for
under subsection (b)).
(4) CONTINUING CARE PATIENT- For purposes of this section, the term
`continuing care patient' means a participant, beneficiary, or enrollee
who--
(A) is undergoing a course of treatment for a serious and complex
condition from the provider at the time the plan or issuer receives or
provides notice of provider, benefit, or coverage termination described in
paragraph (1) (or paragraph (2), if applicable);
(B) is undergoing a course of institutional or inpatient care from the
provider at the time of such notice;
(C) is scheduled to undergo non-elective surgery from the provider at
the time of such notice;
(D) is pregnant and undergoing a course of treatment for the pregnancy
from the provider at the time of such notice; or
(E) is or was determined to be terminally ill (as determined under
section 1861(dd)(3)(A) of the Social Security Act) at the time of such
notice, but only with respect to a provider that was treating the terminal
illness before the date of such notice.
(b) TRANSITIONAL PERIODS-
(1) SERIOUS AND COMPLEX CONDITIONS- The transitional period under this
subsection with respect to a continuing care patient described in subsection
(a)(4)(A) shall extend for up to 90 days (as determined by the treating
health care professional) from the date of the notice described in
subsection (a)(3)(A).
(2) INSTITUTIONAL OR INPATIENT CARE- The transitional period under this
subsection for a continuing care patient described in subsection (a)(4)(B)
shall extend until the earlier of--
(A) the expiration of the 90-day period beginning on the date on which
the notice under subsection (a)(3)(A) is provided; or
(B) the date of discharge of the patient from such care or the
termination of the period of institutionalization, or, if later, the date
of completion of reasonable follow-up care.
(3) SCHEDULED NON-ELECTIVE SURGERY- The transitional period under this
subsection for a continuing care patient described in subsection (a)(4)(C)
shall extend until the completion of the surgery involved and post-surgical
follow-up care relating to the surgery and occurring within 90 days after
the date of the surgery.
(4) PREGNANCY- The transitional period under this subsection for a
continuing care patient described in subsection (a)(4)(D) shall extend
through the provision of post-partum care directly related to the delivery.
(5) TERMINAL ILLNESS- The transitional period under this subsection for
a continuing care patient described in subsection (a)(4)(E) shall extend for
the remainder of the patient's life for care that is directly related to the
treatment of the terminal illness or its medical manifestations.
(c) PERMISSIBLE TERMS AND CONDITIONS- A group health plan or health
insurance issuer may condition coverage of continued treatment by a provider
under this section upon the provider agreeing to the following terms and
conditions:
(1) The treating health care provider agrees to accept reimbursement
from the plan or issuer and continuing care patient involved (with respect
to cost-sharing) at the rates applicable prior to the start of the
transitional period as payment in full (or, in the case described in
subsection (a)(2), at the rates applicable under the replacement plan or
coverage after the date of the termination of the contract with the group
health plan or health insurance issuer) and not to impose cost-sharing with
respect to the patient in an amount that would exceed the cost-sharing that
could have been imposed if the contract referred to in subsection (a)(1) had
not been terminated.
(2) The treating health care provider agrees to adhere to the quality
assurance standards of the plan or issuer responsible for payment under
paragraph (1) and to provide to such plan or issuer necessary medical
information related to the care provided.
(3) The treating health care provider agrees otherwise to adhere to such
plan's or issuer's policies and procedures, including procedures regarding
referrals and obtaining prior authorization and providing services pursuant
to a treatment plan (if any) approved by the plan or issuer.
(d) RULES OF CONSTRUCTION- Nothing in this section shall be construed--
(1) to require the coverage of benefits which would not have been
covered if the provider involved remained a participating provider; or
(2) with respect to the termination of a contract under subsection (a)
to prevent a group health plan or health insurance issuer from requiring
that the health care provider--
(A) notify participants, beneficiaries, or enrollees of their rights
under this section; or
(B) provide the plan or issuer with the name of each participant,
beneficiary, or enrollee who the provider believes is a continuing care
patient.
(e) DEFINITIONS- In this section:
(1) CONTRACT- The term `contract' includes, with respect to a plan or
issuer and a treating health care provider, a contract between such plan or
issuer and an organized network of providers that includes the treating
health care provider, and (in the case of such a contract) the contract
between the treating health care provider and the organized network.
(2) HEALTH CARE PROVIDER- The term `health care provider' or `provider'
means--
(A) any individual who is engaged in the delivery of health care
services in a State and who is required by State law or regulation to be
licensed or certified by the State to engage in the delivery of such
services in the State; and
(B) any entity that is engaged in the delivery of health care services
in a State and that, if it is required by State law or regulation to be
licensed or certified by the State to engage in the delivery of such
services in the State, is so licensed.
(3) SERIOUS AND COMPLEX CONDITION- The term `serious and complex
condition' means, with respect to a participant, beneficiary, or enrollee
under the plan or coverage--
(A) in the case of an acute illness, a condition that is serious
enough to require specialized medical treatment to avoid the reasonable
possibility of death or permanent harm; or
(B) in the case of a chronic illness or condition, is an ongoing
special condition (as defined in section 114(b)(2)(B)).
(4) TERMINATED- The term `terminated' includes, with respect to a
contract, the expiration or nonrenewal of the contract, but does not include
a termination of the contract for failure to meet applicable quality
standards or for fraud.
SEC. 118. ACCESS TO NEEDED PRESCRIPTION DRUGS.
(a) IN GENERAL- To the extent that a group health plan, or health
insurance coverage offered by a health insurance issuer, provides coverage for
benefits with respect to prescription drugs, and limits such coverage to drugs
included in a formulary, the plan or issuer shall--
(1) ensure the participation of physicians and pharmacists in developing
and reviewing such formulary;
(2) provide for disclosure of the formulary to providers; and
(3) in accordance with the applicable quality assurance and utilization
review standards of the plan or issuer, provide for exceptions from the
formulary limitation when a non-formulary alternative is medically necessary
and appropriate and, in the case of such an exception, apply the same
cost-sharing requirements that would have applied in the case of a drug
covered under the formulary.
(b) COVERAGE OF APPROVED DRUGS AND MEDICAL DEVICES-
(1) IN GENERAL- A group health plan (or health insurance coverage
offered in connection with such a plan) that provides any coverage of
prescription drugs or medical devices shall not deny coverage of such a drug
or device on the basis that the use is investigational, if the use--
(A) in the case of a prescription drug--
(i) is included in the labeling authorized by the application in
effect for the drug pursuant to subsection (b) or (j) of
section 505 of the Federal Food, Drug, and Cosmetic Act, without regard to
any postmarketing requirements that may apply under such Act; or
(ii) is included in the labeling authorized by the application in
effect for the drug under section 351 of the Public Health Service Act,
without regard to any postmarketing requirements that may apply pursuant
to such section; or
(B) in the case of a medical device, is included in the labeling
authorized by a regulation under subsection (d) or (3) of section 513 of
the Federal Food, Drug, and Cosmetic Act, an order under subsection (f) of
such section, or an application approved under section 515 of such Act,
without regard to any postmarketing requirements that may apply under such
Act.
(2) CONSTRUCTION- Nothing in this subsection shall be construed as
requiring a group health plan (or health insurance coverage offered in
connection with such a plan) to provide any coverage of prescription drugs
or medical devices.
SEC. 119. COVERAGE FOR INDIVIDUALS PARTICIPATING IN APPROVED CLINICAL
TRIALS.
(1) IN GENERAL- If a group health plan, or health insurance issuer that
is providing health insurance coverage, provides coverage to a qualified
individual (as defined in subsection (b)), the plan or issuer--
(A) may not deny the individual participation in the clinical trial
referred to in subsection (b)(2);
(B) subject to subsection (c), may not deny (or limit or impose
additional conditions on) the coverage of routine patient costs for items
and services furnished in connection with participation in the trial;
and
(C) may not discriminate against the individual on the basis of the
enrollee's participation in such trial.
(2) EXCLUSION OF CERTAIN COSTS- For purposes of paragraph (1)(B),
routine patient costs do not include the cost of the tests or measurements
conducted primarily for the purpose of the clinical trial involved.
(3) USE OF IN-NETWORK PROVIDERS- If one or more participating providers
is participating in a clinical trial, nothing in paragraph (1) shall be
construed as preventing a plan or issuer from requiring that a qualified
individual participate in the trial through such a participating provider if
the provider will accept the individual as a participant in the trial.
(b) QUALIFIED INDIVIDUAL DEFINED- For purposes of subsection (a), the term
`qualified individual' means an individual who is a participant or beneficiary
in a group health plan, or who is an enrollee under health insurance coverage,
and who meets the following conditions:
(1)(A) The individual has a life-threatening or serious illness for
which no standard treatment is effective.
(B) The individual is eligible to participate in an approved clinical
trial according to the trial protocol with respect to treatment of such
illness.
(C) The individual's participation in the trial offers meaningful
potential for significant clinical benefit for the individual.
(A) the referring physician is a participating health care
professional and has concluded that the individual's participation in such
trial would be appropriate based upon the individual meeting the
conditions described in paragraph (1); or
(B) the participant, beneficiary, or enrollee provides medical and
scientific information establishing that the individual's participation in
such trial would be appropriate based upon the individual meeting the
conditions described in paragraph (1).
(1) IN GENERAL- Under this section a group health plan or health
insurance issuer shall provide for payment for routine patient costs
described in subsection (a)(2) but is not required to pay for costs of items
and services that are reasonably expected (as determined by the appropriate
Secretary) to be paid for by the sponsors of an approved clinical
trial.
(2) PAYMENT RATE- In the case of covered items and services provided
by--
(A) a participating provider, the payment rate shall be at the agreed
upon rate; or
(B) a nonparticipating provider, the payment rate shall be at the rate
the plan or issuer would normally pay for comparable services under
subparagraph (A).
(d) APPROVED CLINICAL TRIAL DEFINED-
(1) IN GENERAL- In this section, the term `approved clinical trial'
means a clinical research study or clinical investigation approved and
funded (which may include funding through in-kind contributions) by one or
more of the following:
(A) The National Institutes of Health.
(B) A cooperative group or center of the National Institutes of
Health.
(C) The Food and Drug Administration.
(D) Either of the following if the conditions described in paragraph
(2) are met:
(i) The Department of Veterans Affairs.
(ii) The Department of Defense.
(2) CONDITIONS FOR DEPARTMENTS- The conditions described in this
paragraph, for a study or investigation conducted by a Department, are that
the study or investigation has been reviewed and approved through a system
of peer review that the appropriate Secretary determines--
(A) to be comparable to the system of peer review of studies and
investigations used by the National Institutes of Health; and
(B) assures unbiased review of the highest scientific standards by
qualified individuals who have no interest in the outcome of the
review.
(e) CONSTRUCTION- Nothing in this section shall be construed to limit a
plan's or issuer's coverage with respect to clinical trials.
SEC. 120. REQUIRED COVERAGE FOR MINIMUM HOSPITAL STAY FOR MASTECTOMIES AND
LYMPH NODE DISSECTIONS FOR THE TREATMENT OF BREAST CANCER AND COVERAGE FOR
SECONDARY CONSULTATIONS.
(1) IN GENERAL- A group health plan, and a health insurance issuer
providing health insurance coverage, that provides medical and surgical
benefits shall ensure that inpatient coverage with respect to the treatment
of breast cancer is provided for a period of time as is determined by the
attending physician, in consultation with the patient, to be medically
necessary and appropriate following--
(C) a lymph node dissection for the treatment of breast
cancer.
(2) EXCEPTION- Nothing in this section shall be construed as requiring
the provision of inpatient coverage if the attending physician and patient
determine that a shorter period of hospital stay is medically
appropriate.
(b) PROHIBITION ON CERTAIN MODIFICATIONS- In implementing the requirements
of this section, a group health plan, and a health insurance issuer providing
health insurance coverage, may not modify the terms and conditions of coverage
based on the determination by a participant, beneficiary, or enrollee to
request less than the minimum coverage required under subsection (a).
(c) SECONDARY CONSULTATIONS-
(1) IN GENERAL- A group health plan, and a health insurance issuer
providing health insurance coverage, that provides coverage with respect to
medical and surgical services provided in relation to the diagnosis and
treatment of cancer shall ensure that full coverage is provided for
secondary consultations by specialists in the appropriate medical fields
(including pathology, radiology, and oncology) to confirm or refute such
diagnosis. Such plan or issuer shall ensure that full coverage is provided
for such secondary consultation whether such consultation is based on a
positive or negative initial diagnosis. In any case in which the attending
physician certifies in writing that services necessary for such a secondary
consultation are not sufficiently available from specialists operating under
the plan or coverage with respect to whose services coverage is otherwise
provided under such plan or by such issuer, such plan or issuer shall ensure
that coverage is provided with respect to the services necessary for the
secondary consultation with any other specialist selected by the attending
physician for such purpose at no additional cost to the individual beyond
that which the individual would have paid if the specialist was
participating in the network of the plan or issuer.
(2) EXCEPTION- Nothing in paragraph (1) shall be construed as requiring
the provision of secondary consultations where the patient determines not to
seek such a consultation.
(d) PROHIBITION ON PENALTIES OR INCENTIVES- A group health plan, and a
health insurance issuer providing health insurance coverage, may not--
(1) penalize or otherwise reduce or limit the reimbursement of a
provider or specialist because the provider or specialist provided care to a
participant, beneficiary, or enrollee in accordance with this section;
(2) provide financial or other incentives to a physician or specialist
to induce the physician or specialist to keep the length of inpatient stays
of patients following a mastectomy, lumpectomy, or a lymph node dissection
for the treatment of breast cancer below certain limits or to limit
referrals for secondary consultations; or
(3) provide financial or other incentives to a physician or specialist
to induce the physician or specialist to refrain from referring a
participant, beneficiary, or enrollee for a secondary consultation that
would otherwise be covered by the plan or coverage involved under subsection
(c).
Subtitle C--Access to Information
SEC. 121. PATIENT ACCESS TO INFORMATION.
(A) IN GENERAL- A group health plan, and a health insurance issuer
that provides coverage in connection with health insurance coverage, shall
provide for the disclosure to participants, beneficiaries, and
enrollees--
(i) of the information described in subsection (b) at the time of
the initial enrollment of the participant, beneficiary, or enrollee
under the plan or coverage;
(ii) of such information on an annual basis--
(I) in conjunction with the election period of the plan or
coverage if the plan or coverage has such an election period;
or
(II) in the case of a plan or coverage that does not have an
election period, in conjunction with the beginning of the plan or
coverage year; and
(iii) of information relating to any material reduction to the
benefits or information described in such subsection or subsection (c),
in the form of a notice provided not later than 30 days before the date
on which the reduction takes effect.
(B) PARTICIPANTS, BENEFICIARIES, AND ENROLLEES- The disclosure
required under subparagraph (A) shall be provided--
(i) jointly to each participant, beneficiary, and enrollee who
reside at the same address; or
(ii) in the case of a beneficiary or enrollee who does not reside at
the same address as the participant or another enrollee, separately to
the participant or other enrollees and such beneficiary or
enrollee.
(2) PROVISION OF INFORMATION- Information shall be provided to
participants, beneficiaries, and enrollees under this section at the last
known address maintained by the plan or issuer with respect to such
participants, beneficiaries, or enrollees, to the extent that such
information is provided to participants, beneficiaries, or enrollees via the
United States Postal Service or other private delivery service.
(b) REQUIRED INFORMATION- The informational materials to be distributed
under this section shall include for each option available under the group
health plan or health insurance coverage the following:
(1) BENEFITS- A description of the covered benefits, including--
(A) any in- and out-of-network benefits;
(B) specific preventive services covered under the plan or coverage if
such services are covered;
(C) any specific exclusions or express limitations of benefits
described in section 104(b)(3)(C);
(D) any other benefit limitations, including any annual or lifetime
benefit limits and any monetary limits or limits on the number of visits,
days, or services, and any specific coverage exclusions; and
(E) any definition of medical necessity used in making coverage
determinations by the plan, issuer, or claims administrator.
(2) COST SHARING- A description of any cost-sharing requirements,
including--
(A) any premiums, deductibles, coinsurance, copayment amounts, and
liability for balance billing, for which the participant, beneficiary, or
enrollee will be responsible under each option available under the
plan;
(B) any maximum out-of-pocket expense for which the participant,
beneficiary, or enrollee may be liable;
(C) any cost-sharing requirements for out-of-network benefits or
services received from nonparticipating providers; and
(D) any additional cost-sharing or charges for benefits and services
that are furnished without meeting applicable plan or coverage
requirements, such as prior authorization or precertification.
(3) SERVICE AREA- A description of the plan or issuer's service area,
including the provision of any out-of-area coverage.
(4) PARTICIPATING PROVIDERS- A directory of participating providers (to
the extent a plan or issuer provides coverage through a network of
providers) that includes, at a minimum, the name, address, and telephone
number of each participating provider, and information about how to inquire
whether a participating provider is currently accepting new patients.
(5) CHOICE OF PRIMARY CARE PROVIDER- A description of any requirements
and procedures to be used by participants, beneficiaries, and enrollees in
selecting, accessing, or changing their primary care provider, including
providers both within and outside of the network (if the plan or issuer
permits out-of-network services), and the right to select a pediatrician as
a primary care provider under section 116 for a participant, beneficiary, or
enrollee who is a child if such section applies.
(6) PREAUTHORIZATION REQUIREMENTS- A description of the requirements and
procedures to be used to obtain preauthorization for health services, if
such preauthorization is required.
(7) EXPERIMENTAL AND INVESTIGATIONAL TREATMENTS- A description of the
process for determining whether a particular item, service, or treatment is
considered experimental or investigational, and the circumstances under
which such treatments are covered by the plan or issuer.
(8) SPECIALTY CARE- A description of the requirements and procedures to
be used by participants, beneficiaries, and enrollees in accessing specialty
care and obtaining referrals to participating and nonparticipating
specialists, including any limitations on choice of health care
professionals referred to in section 112(b)(2) and the right to timely
access to specialists care under section 114 if such section applies.
(9) CLINICAL TRIALS- A description of the circumstances and conditions
under which participation in clinical trials is covered under the terms and
conditions of the plan or coverage, and the right to obtain coverage for
approved clinical trials under section 119 if such section applies.
(10) PRESCRIPTION DRUGS- To the extent the plan or issuer provides
coverage for prescription drugs, a statement of whether such coverage is
limited to drugs included in a formulary, a description of any provisions
and cost-sharing required for obtaining on- and off-formulary medications,
and a description of the rights of participants, beneficiaries, and
enrollees in obtaining access to access to prescription drugs under section
118 if such section applies.
(11) EMERGENCY SERVICES- A summary of the rules and procedures for
accessing emergency services, including the right of a participant,
beneficiary, or enrollee to obtain emergency services under the prudent
layperson standard under section 113, if such section applies, and any
educational information that the plan or issuer may provide regarding the
appropriate use of emergency services.
(12) CLAIMS AND APPEALS- A description of the plan or issuer's rules and
procedures pertaining to claims and appeals, a description of the rights
(including deadlines for exercising rights) of participants, beneficiaries,
and enrollees under subtitle A
in obtaining covered benefits, filing a claim for benefits, and appealing
coverage decisions internally and externally (including telephone numbers and
mailing addresses of the appropriate authority), and a description of any
additional legal rights and remedies available under section 502 of the Employee
Retirement Income Security Act of 1974 and applicable State law.
(13) ADVANCE DIRECTIVES AND ORGAN DONATION- A description of procedures
for advance directives and organ donation decisions if the plan or issuer
maintains such procedures.
(14) INFORMATION ON PLANS AND ISSUERS- The name, mailing address, and
telephone number or numbers of the plan administrator and the issuer to be
used by participants, beneficiaries, and enrollees seeking information about
plan or coverage benefits and services, payment of a claim, or authorization
for services and treatment. Notice of whether the benefits under the plan or
coverage are provided under a contract or policy of insurance issued by an
issuer, or whether benefits are provided directly by the plan sponsor who
bears the insurance risk.
(15) TRANSLATION SERVICES- A summary description of any translation or
interpretation services (including the availability of printed information
in languages other than English, audio tapes, or information in Braille)
that are available for non-English speakers and participants, beneficiaries,
and enrollees with communication disabilities and a description of how to
access these items or services.
(16) ACCREDITATION INFORMATION- Any information that is made public by
accrediting organizations in the process of accreditation if the plan or
issuer is accredited, or any additional quality indicators (such as the
results of enrollee satisfaction surveys) that the plan or issuer makes
public or makes available to participants, beneficiaries, and
enrollees.
(17) NOTICE OF REQUIREMENTS- A description of any rights of
participants, beneficiaries, and enrollees that are established by the
Bipartisan Patient Protection Act of 2001 (excluding those described in
paragraphs (1) through (16)) if such sections apply. The description
required under this paragraph may be combined with the notices of the type
described in sections 711(d), 713(b), or 606(a)(1) of the Employee
Retirement Income Security Act of 1974 and with any other notice provision
that the appropriate Secretary determines may be combined, so long as such
combination does not result in any reduction in the information that would
otherwise be provided to the recipient.
(18) AVAILABILITY OF ADDITIONAL INFORMATION- A statement that the
information described in subsection (c), and instructions on obtaining such
information (including telephone numbers and, if available, Internet
websites), shall be made available upon request.
(c) ADDITIONAL INFORMATION- The informational materials to be provided
upon the request of a participant, beneficiary, or enrollee shall include for
each option available under a group health plan or health insurance coverage
the following:
(1) STATUS OF PROVIDERS- The State licensure status of the plan or
issuer's participating health care professionals and participating health
care facilities, and, if available, the education, training, specialty
qualifications or certifications of such professionals.
(2) COMPENSATION METHODS- A summary description by category of the
applicable methods (such as capitation, fee-for-service, salary, bundled
payments, per diem, or a combination thereof) used for compensating
prospective or treating health care professionals (including primary care
providers and specialists) and facilities in connection with the provision
of health care under the plan or coverage.
(3) PRESCRIPTION DRUGS- Information about whether a specific
prescription medication is included in the formulary of the plan or issuer,
if the plan or issuer uses a defined formulary.
(4) EXTERNAL APPEALS INFORMATION- Aggregate information on the number
and outcomes of external medical reviews, relative to the sample size (such
as the number of covered lives) under the plan or under the coverage of the
issuer.
(d) MANNER OF DISCLOSURE- The information described in this section shall
be disclosed in an accessible medium and format that is calculated to be
understood by an average participant or enrollee.
(e) RULES OF CONSTRUCTION- Nothing in this section shall be construed to
prohibit a group health plan, or a health insurance issuer in connection with
health insurance coverage, from--
(1) distributing any other additional information determined by the plan
or issuer to be important or necessary in assisting participants,
beneficiaries, and enrollees in the selection of a health plan or health
insurance coverage; and
(2) complying with the provisions of this section by providing
information in brochures, through the Internet or other electronic media, or
through other similar means, so long as--
(A) the disclosure of such information in such form is in accordance
with requirements as the appropriate Secretary may impose, and
(B) in connection with any such disclosure of information through the
Internet or other electronic media--
(i) the recipient has affirmatively consented to the disclosure of
such information in such form,
(ii) the recipient is capable of accessing the information so
disclosed on the recipient's individual workstation or at the
recipient's home,
(iii) the recipient retains an ongoing right to receive paper
disclosure of such information and receives, in advance of any attempt
at disclosure of such information to him or her through the Internet or
other electronic media, notice in printed form of such ongoing right and
of the
proper software required to view information so disclosed, and
(iv) the plan administrator appropriately ensures that the intended
recipient is receiving the information so disclosed and provides the
information in printed form if the information is not
received.
Subtitle D--Protecting the Doctor-Patient Relationship
SEC. 131. PROHIBITION OF INTERFERENCE WITH CERTAIN MEDICAL
COMMUNICATIONS.
(a) GENERAL RULE- The provisions of any contract or agreement, or the
operation of any contract or agreement, between a group health plan or health
insurance issuer in relation to health insurance coverage (including any
partnership, association, or other organization that enters into or
administers such a contract or agreement) and a health care provider (or group
of health care providers) shall not prohibit or otherwise restrict a health
care professional from advising such a participant, beneficiary, or enrollee
who is a patient of the professional about the health status of the individual
or medical care or treatment for the individual's condition or disease,
regardless of whether benefits for such care or treatment are provided under
the plan or coverage, if the professional is acting within the lawful scope of
practice.
(b) NULLIFICATION- Any contract provision or agreement that restricts or
prohibits medical communications in violation of subsection (a) shall be null
and void.
SEC. 132. PROHIBITION OF DISCRIMINATION AGAINST PROVIDERS BASED ON
LICENSURE.
(a) IN GENERAL- A group health plan, and a health insurance issuer with
respect to health insurance coverage, shall not discriminate with respect to
participation or indemnification as to any provider who is acting within the
scope of the provider's license or certification under applicable State law,
solely on the basis of such license or certification.
(b) CONSTRUCTION- Subsection (a) shall not be construed--
(1) as requiring the coverage under a group health plan or health
insurance coverage of a particular benefit or service or to prohibit a plan
or issuer from including providers only to the extent necessary to meet the
needs of the plan's or issuer's participants, beneficiaries, or enrollees or
from establishing any measure designed to maintain quality and control costs
consistent with the responsibilities of the plan or issuer;
(2) to override any State licensure or scope-of-practice law; or
(3) as requiring a plan or issuer that offers network coverage to
include for participation every willing provider who meets the terms and
conditions of the plan or issuer.
SEC. 133. PROHIBITION AGAINST IMPROPER INCENTIVE ARRANGEMENTS.
(a) IN GENERAL- A group health plan and a health insurance issuer offering
health insurance coverage may not operate any physician incentive plan (as
defined in subparagraph (B) of section 1876(i)(8) of the Social Security Act)
unless the requirements described in clauses (i), (ii)(I), and (iii) of
subparagraph (A) of such section are met with respect to such a plan.
(b) APPLICATION- For purposes of carrying out paragraph (1), any reference
in section 1876(i)(8) of the Social Security Act to the Secretary, an eligible
organization, or an individual enrolled with the organization shall be treated
as a reference to the applicable authority, a group health plan or health
insurance issuer, respectively, and a participant, beneficiary, or enrollee
with the plan or organization, respectively.
(c) CONSTRUCTION- Nothing in this section shall be construed as
prohibiting all capitation and similar arrangements or all provider discount
arrangements.
SEC. 134. PAYMENT OF CLAIMS.
A group health plan, and a health insurance issuer offering group health
insurance coverage, shall provide for prompt payment of claims submitted for
health care services or supplies furnished to a participant, beneficiary, or
enrollee with respect to benefits covered by the plan or issuer, in a manner
consistent with the provisions of section 1842(c)(2) of the Social Security
Act (42 U.S.C. 1395u(c)(2)).
SEC. 135. PROTECTION FOR PATIENT ADVOCACY.
(a) PROTECTION FOR USE OF UTILIZATION REVIEW AND GRIEVANCE PROCESS- A
group health plan, and a health insurance issuer with respect to the provision
of health insurance coverage, may not retaliate against a participant,
beneficiary, enrollee, or health care provider based on the participant's,
beneficiary's, enrollee's or provider's use of, or participation in, a
utilization review process or a grievance process of the plan or issuer
(including an internal or external review or appeal process) under this
title.
(b) PROTECTION FOR QUALITY ADVOCACY BY HEALTH CARE PROFESSIONALS-
(1) IN GENERAL- A group health plan or health insurance issuer may not
retaliate or discriminate against a protected health care professional
because the professional in good faith--
(A) discloses information relating to the care, services, or
conditions affecting one or more participants, beneficiaries, or enrollees
of the plan or issuer to an appropriate public regulatory agency, an
appropriate private accreditation body, or appropriate management
personnel of the plan or issuer; or
(B) initiates, cooperates, or otherwise participates in an
investigation or proceeding by such an agency with respect to such care,
services, or conditions.
If an institutional health care provider is a participating provider
with such a plan or issuer or otherwise receives payments for benefits
provided by such a plan or issuer, the provisions of the previous sentence
shall apply to the provider in relation to care, services, or conditions
affecting one or more patients within an institutional health care provider
in the same manner as they apply to the plan or issuer in relation to care,
services, or conditions provided to one or more participants, beneficiaries,
or enrollees;
and for purposes of applying this sentence, any reference to a plan or issuer
is deemed a reference to the institutional health care provider.
(2) GOOD FAITH ACTION- For purposes of paragraph (1), a protected health
care professional is considered to be acting in good faith with respect to
disclosure of information or participation if, with respect to the
information disclosed as part of the action--
(A) the disclosure is made on the basis of personal knowledge and is
consistent with that degree of learning and skill ordinarily possessed by
health care professionals with the same licensure or certification and the
same experience;
(B) the professional reasonably believes the information to be
true;
(C) the information evidences either a violation of a law, rule, or
regulation, of an applicable accreditation standard, or of a generally
recognized professional or clinical standard or that a patient is in
imminent hazard of loss of life or serious injury; and
(D) subject to subparagraphs (B) and (C) of paragraph (3), the
professional has followed reasonable internal procedures of the plan,
issuer, or institutional health care provider established for the purpose
of addressing quality concerns before making the disclosure.
(3) EXCEPTION AND SPECIAL RULE-
(A) GENERAL EXCEPTION- Paragraph (1) does not protect disclosures that
would violate Federal or State law or diminish or impair the rights of any
person to the continued protection of confidentiality of communications
provided by such law.
(B) NOTICE OF INTERNAL PROCEDURES- Subparagraph (D) of paragraph (2)
shall not apply unless the internal procedures involved are reasonably
expected to be known to the health care professional involved. For
purposes of this subparagraph, a health care professional is reasonably
expected to know of internal procedures if those procedures have been made
available to the professional through distribution or posting.
(C) INTERNAL PROCEDURE EXCEPTION- Subparagraph (D) of paragraph (2)
also shall not apply if--
(i) the disclosure relates to an imminent hazard of loss of life or
serious injury to a patient;
(ii) the disclosure is made to an appropriate private accreditation
body pursuant to disclosure procedures established by the body;
or
(iii) the disclosure is in response to an inquiry made in an
investigation or proceeding of an appropriate public regulatory agency
and the information disclosed is limited to the scope of the
investigation or proceeding.
(4) ADDITIONAL CONSIDERATIONS- It shall not be a violation of paragraph
(1) to take an adverse action against a protected health care professional
if the plan, issuer, or provider taking the adverse action involved
demonstrates that it would have taken the same adverse action even in the
absence of the activities protected under such paragraph.
(5) NOTICE- A group health plan, health insurance issuer, and
institutional health care provider shall post a notice, to be provided or
approved by the Secretary of Labor, setting forth excerpts from, or
summaries of, the pertinent provisions of this subsection and information
pertaining to enforcement of such provisions.
(A) DETERMINATIONS OF COVERAGE- Nothing in this subsection shall be
construed to prohibit a plan or issuer from making a determination not to
pay for a particular medical treatment or service or the services of a
type of health care professional.
(B) ENFORCEMENT OF PEER REVIEW PROTOCOLS AND INTERNAL PROCEDURES-
Nothing in this subsection shall be construed to prohibit a plan, issuer,
or provider from establishing and enforcing reasonable peer review or
utilization review protocols or determining whether a protected health
care professional has complied with those protocols or from establishing
and enforcing internal procedures for the purpose of addressing quality
concerns.
(C) RELATION TO OTHER RIGHTS- Nothing in this subsection shall be
construed to abridge rights of participants, beneficiaries, enrollees, and
protected health care professionals under other applicable Federal or
State laws.
(7) PROTECTED HEALTH CARE PROFESSIONAL DEFINED- For purposes of this
subsection, the term `protected health care professional' means an
individual who is a licensed or certified health care professional and
who--
(A) with respect to a group health plan or health insurance issuer, is
an employee of the plan or issuer or has a contract with the plan or
issuer for provision of services for which benefits are available under
the plan or issuer; or
(B) with respect to an institutional health care provider, is an
employee of the provider or has a contract or other arrangement with the
provider respecting the provision of health care services.
Subtitle E--Definitions
SEC. 151. DEFINITIONS.
(a) INCORPORATION OF GENERAL DEFINITIONS- Except as otherwise provided,
the provisions of section 2791 of the Public Health Service Act shall apply
for purposes of this title in the same manner as they apply for purposes of
title XXVII of such Act.
(b) SECRETARY- Except as otherwise provided, the term `Secretary' means
the Secretary of Health and Human Services, in consultation with the Secretary
of
Labor and the term `appropriate Secretary' means the Secretary of Health and
Human Services in relation to carrying out this title under sections 2706 and
2751 of the Public Health Service Act and the Secretary of Labor in relation to
carrying out this title under section 713 of the Employee Retirement Income
Security Act of 1974.
(c) ADDITIONAL DEFINITIONS- For purposes of this title:
(1) APPLICABLE AUTHORITY- The term `applicable authority' means--
(A) in the case of a group health plan, the Secretary of Health and
Human Services and the Secretary of Labor; and
(B) in the case of a health insurance issuer with respect to a
specific provision of this title, the applicable State authority (as
defined in section 2791(d) of the Public Health Service Act), or the
Secretary of Health and Human Services, if such Secretary is enforcing
such provision under section 2722(a)(2) or 2761(a)(2) of the Public Health
Service Act.
(2) ENROLLEE- The term `enrollee' means, with respect to health
insurance coverage offered by a health insurance issuer, an individual
enrolled with the issuer to receive such coverage.
(3) GROUP HEALTH PLAN- The term `group health plan' has the meaning
given such term in section 733(a) of the Employee Retirement Income Security
Act of 1974, except that such term includes a employee welfare benefit plan
treated as a group health plan under section 732(d) of such Act or defined
as such a plan under section 607(1) of such Act.
(4) HEALTH CARE PROFESSIONAL- The term `health care professional' means
an individual who is licensed, accredited, or certified under State law to
provide specified health care services and who is operating within the scope
of such licensure, accreditation, or certification.
(5) HEALTH CARE PROVIDER- The term `health care provider' includes a
physician or other health care professional, as well as an institutional or
other facility or agency that provides health care services and that is
licensed, accredited, or certified to provide health care items and services
under applicable State law.
(6) NETWORK- The term `network' means, with respect to a group health
plan or health insurance issuer offering health insurance coverage, the
participating health care professionals and providers through whom the plan
or issuer provides health care items and services to participants,
beneficiaries, or enrollees.
(7) NONPARTICIPATING- The term `nonparticipating' means, with respect to
a health care provider that provides health care items and services to a
participant, beneficiary, or enrollee under group health plan or health
insurance coverage, a health care provider that is not a participating
health care provider with respect to such items and services.
(8) PARTICIPATING- The term `participating' means, with respect to a
health care provider that provides health care items and services to a
participant, beneficiary, or enrollee under group health plan or health
insurance coverage offered by a health insurance issuer, a health care
provider that furnishes such items and services under a contract or other
arrangement with the plan or issuer.
(9) PRIOR AUTHORIZATION- The term `prior authorization' means the
process of obtaining prior approval from a health insurance issuer or group
health plan for the provision or coverage of medical services.
(10) TERMS AND CONDITIONS- The term `terms and conditions' includes,
with respect to a group health plan or health insurance coverage,
requirements imposed under this title with respect to the plan or
coverage.
SEC. 152. PREEMPTION; STATE FLEXIBILITY; CONSTRUCTION.
(a) CONTINUED APPLICABILITY OF STATE LAW WITH RESPECT TO HEALTH INSURANCE
ISSUERS-
(1) IN GENERAL- Subject to paragraph (2), this title shall not be
construed to supersede any provision of State law which establishes,
implements, or continues in effect any standard or requirement solely
relating to health insurance issuers (in connection with group health
insurance coverage or otherwise) except to the extent that such standard or
requirement prevents the application of a requirement of this title.
(2) CONTINUED PREEMPTION WITH RESPECT TO GROUP HEALTH PLANS- Nothing in
this title shall be construed to affect or modify the provisions of section
514 of the Employee Retirement Income Security Act of 1974 with respect to
group health plans.
(3) CONSTRUCTION- In applying this section, a State law that provides
for equal access to, and availability of, all categories of licensed health
care providers and services shall not be treated as preventing the
application of any requirement of this title.
(b) APPLICATION OF SUBSTANTIALLY EQUIVALENT STATE LAWS-
(1) IN GENERAL- In the case of a State law that imposes, with respect to
health insurance coverage offered by a health insurance issuer and with
respect to a group health plan that is a non-Federal governmental plan, a
requirement that is substantially equivalent (within the meaning of
subsection (c)) to a patient protection requirement (as defined in paragraph
(3)) and does not prevent the application of other requirements under this
Act (except in the case of other substantially equivalent requirements), in
applying the requirements of this title under section 2707 and 2753 (as
applicable) of the Public Health Service Act (as added by title II), subject
to subsection (a)(2)--
(A) the State law shall not be treated as being superseded under
subsection (a); and
(B) the State law shall apply instead of the patient protection
requirement otherwise applicable with respect to health insurance coverage
and non-Federal governmental plans.
(2) LIMITATION- In the case of a group health plan covered under title I
of the Employee Retirement Income Security Act of 1974, paragraph (1) shall
be construed to apply only with respect to the health insurance coverage (if
any) offered in connection with the plan.
(3) PATIENT PROTECTION REQUIREMENT DEFINED- For purposes of this
section, the term `patient protection requirement' means a requirement under
this title, and includes (as a single requirement) a group or related set of
requirements under a section or similar unit under this title.
(c) DETERMINATIONS OF SUBSTANTIAL EQUIVALENCE-
(1) CERTIFICATION BY STATES- A State may submit to the Secretary a
certification that a State law provides for patient protections that are at
least substantially equivalent to one or more patient protection
requirements. Such certification shall be accompanied by such information as
may be required to permit the Secretary to make the determination described
in paragraph (2)(A).
(A) IN GENERAL- The Secretary shall promptly review a certification
submitted under paragraph (1) with respect to a State law to determine if
the State law provides for at least substantially equivalent and effective
patient protections to the patient protection requirement (or
requirements) to which the law relates.
(i) INITIAL REVIEW- Such a certification is considered approved
unless the Secretary notifies the State in writing, within 90 days after
the date of receipt of the certification, that the certification is
disapproved (and the reasons for disapproval) or that specified
additional information is needed to make the determination described in
subparagraph (A).
(ii) ADDITIONAL INFORMATION- With respect to a State that has been
notified by the Secretary under clause (i) that specified additional
information is needed to make the determination described in
subparagraph (A), the Secretary shall make the determination within 60
days after the date on which such specified additional information is
received by the Secretary.
(A) IN GENERAL- The Secretary shall approve a certification under
paragraph (1) unless--
(i) the State fails to provide sufficient information to enable the
Secretary to make a determination under paragraph (2)(A); or
(ii) the Secretary determines that the State law involved does not
provide for patient protections that are at least substantially
equivalent to and as effective as the patient protection requirement (or
requirements) to which the law relates.
(B) STATE CHALLENGE- A State that has a certification disapproved by
the Secretary under subparagraph (A) may challenge such disapproval in the
appropriate United States district court.
(4) CONSTRUCTION- Nothing in this subsection shall be construed as
preventing the certification (and approval of certification) of a State law
under this subsection solely because it provides for greater protections for
patients than those protections otherwise required to establish substantial
equivalence.
(d) DEFINITIONS- For purposes of this section:
(1) STATE LAW- The term `State law' includes all laws, decisions, rules,
regulations, or other State action having the effect of law, of any State. A
law of the United States applicable only to the District of Columbia shall
be treated as a State law rather than a law of the United States.
(2) STATE- The term `State' includes a State, the District of Columbia,
Puerto Rico, the Virgin Islands, Guam, American Samoa, the Northern Mariana
Islands, any political subdivisions of such, or any agency or
instrumentality of such.
SEC. 153. EXCLUSIONS.
(a) NO BENEFIT REQUIREMENTS- Nothing in this title shall be construed to
require a group health plan or a health insurance issuer offering health
insurance coverage to include specific items and services under the terms of
such a plan or coverage, other than those provided under the terms and
conditions of such plan or coverage.
(b) EXCLUSION FROM ACCESS TO CARE MANAGED CARE PROVISIONS FOR
FEE-FOR-SERVICE COVERAGE-
(1) IN GENERAL- The provisions of sections 111 through 117 shall not
apply to a group health plan or health insurance coverage if the only
coverage offered under the plan or coverage is fee-for-service coverage (as
defined in paragraph (2)).
(2) FEE-FOR-SERVICE COVERAGE DEFINED- For purposes of this subsection,
the term `fee-for-service coverage' means coverage under a group health plan
or health insurance coverage that--
(A) reimburses hospitals, health professionals, and other providers on
a fee-for-service basis without placing the provider at financial
risk;
(B) does not vary reimbursement for such a provider based on an
agreement to contract terms and conditions or the utilization of health
care items or services relating to such provider;
(C) allows access to any provider that is lawfully authorized to
provide the covered services and that agrees to accept the terms and
conditions of payment established under the plan or by the issuer;
and
(D) for which the plan or issuer does not require prior authorization
before providing for any health care services.
SEC. 154. COVERAGE OF LIMITED SCOPE PLANS.
Only for purposes of applying the requirements of this title under
sections 2707 and 2753 of the Public Health Service Act and section 714 of the
Employee Retirement Income Security Act of 1974, section 2791(c)(2)(A), and
section 733(c)(2)(A) of the Employee Retirement Income Security Act of 1974
shall be deemed not to apply.
SEC. 155. REGULATIONS.
The Secretaries of Health and Human Services and Labor shall issue such
regulations as may be necessary or appropriate to carry out this title. Such
regulations shall be issued consistent with section 104 of Health Insurance
Portability and Accountability Act of 1996. Such Secretaries may promulgate
any interim final rules as the Secretaries determine are appropriate to carry
out this title.
SEC. 156. INCORPORATION INTO PLAN OR COVERAGE DOCUMENTS.
The requirements of this title with respect to a group health plan or
health insurance coverage are deemed to be incorporated into, and made a part
of, such plan or the policy, certificate, or contract providing such coverage
and are enforceable under law as if directly included in the documentation of
such plan or such policy, certificate, or contract.
TITLE II--APPLICATION OF QUALITY CARE STANDARDS TO GROUP HEALTH PLANS
AND HEALTH INSURANCE COVERAGE UNDER THE PUBLIC HEALTH SERVICE ACT
SEC. 201. APPLICATION TO GROUP HEALTH PLANS AND GROUP HEALTH INSURANCE
COVERAGE.
(a) IN GENERAL- Subpart 2 of part A of title XXVII of the Public Health
Service Act is amended by adding at the end the following new section:
`SEC. 2707. PATIENT PROTECTION STANDARDS.
`Each group health plan shall comply with patient protection requirements
under title I of the Bipartisan Patient Protection Act of 2001, and each
health insurance issuer shall comply with patient protection requirements
under such title with respect to group health insurance coverage it offers,
and such requirements shall be deemed to be incorporated into this
subsection.'.
(b) CONFORMING AMENDMENT- Section 2721(b)(2)(A) of such Act (42 U.S.C.
300gg-21(b)(2)(A)) is amended by inserting `(other than section 2707)' after
`requirements of such subparts'.
SEC. 202. APPLICATION TO INDIVIDUAL HEALTH INSURANCE COVERAGE.
Part B of title XXVII of the Public Health Service Act is amended by
inserting after section 2752 the following new section:
`SEC. 2753. PATIENT PROTECTION STANDARDS.
`Each health insurance issuer shall comply with patient protection
requirements under title I of the Bipartisan Patient Protection Act of 2001
with respect to individual health insurance coverage it offers, and such
requirements shall be deemed to be incorporated into this subsection.'.
TITLE III--AMENDMENTS TO THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF
1974
SEC. 301. APPLICATION OF PATIENT PROTECTION STANDARDS TO GROUP HEALTH PLANS
AND GROUP HEALTH INSURANCE COVERAGE UNDER THE EMPLOYEE RETIREMENT INCOME
SECURITY ACT OF 1974.
Subpart B of part 7 of subtitle B of title I of the Employee Retirement
Income Security Act of 1974 is amended by adding at the end the following new
section:
`SEC. 714. PATIENT PROTECTION STANDARDS.
`(a) IN GENERAL- Subject to subsection (b), a group health plan (and a
health insurance issuer offering group health insurance coverage in connection
with such a plan) shall comply with the requirements of title I of the
Bipartisan Patient Protection Act of 2001 (as in effect as of the date of the
enactment of such Act), and such requirements shall be deemed to be
incorporated into this subsection.
`(b) PLAN SATISFACTION OF CERTAIN REQUIREMENTS-
`(1) SATISFACTION OF CERTAIN REQUIREMENTS THROUGH INSURANCE- For
purposes of subsection (a), insofar as a group health plan provides benefits
in the form of health insurance coverage through a health insurance issuer,
the plan shall be treated as meeting the following requirements of title I
of the Bipartisan Patient Protection Act of 2001 with respect to such
benefits and not be considered as failing to meet such requirements because
of a failure of the issuer to meet such requirements so long as the plan
sponsor or its representatives did not cause such failure by the
issuer:
`(A) Section 111 (relating to consumer choice option).
`(B) Section 112 (relating to choice of health care
professional).
`(C) Section 113 (relating to access to emergency care).
`(D) Section 114 (relating to timely access to specialists).
`(E) Section 115 (relating to patient access to obstetrical and
gynecological care).
`(F) Section 116 (relating to access to pediatric care).
`(G) Section 117 (relating to continuity of care), but only insofar as
a replacement issuer assumes the obligation for continuity of
care.
`(H) Section 118 (relating to access to needed prescription
drugs).
`(I) Section 119 (relating to coverage for individuals participating
in approved clinical trials).
`(J) Section 120 (relating to required coverage for minimum hospital
stay for mastectomies and lymph node dissections for the treatment of
breast cancer and coverage for secondary consultations).
`(K) Section 134 (relating to payment of claims).
`(2) INFORMATION- With respect to information required to be provided or
made available under section 121 of the Bipartisan Patient Protection Act of
2001, in the case of a group health plan that provides benefits in the form
of health insurance coverage through a health insurance issuer, the
Secretary shall determine the circumstances under which the plan is not
required to provide or make available the information (and is not liable for
the issuer's failure to provide or make available the information), if the
issuer is obligated to provide and make available (or provides and makes
available) such information.
`(3) INTERNAL APPEALS- With respect to the internal appeals process
required to be established under section 103 of such Act, in the case of a
group health plan that provides benefits in the form of health insurance
coverage through a health insurance issuer, the Secretary shall determine
the circumstances under which the plan is not required to provide for such
process and system (and is not liable for the issuer's failure to provide
for such process and system), if the issuer is obligated to provide for (and
provides for) such process and system.
`(4) EXTERNAL APPEALS- Pursuant to rules of the Secretary, insofar as a
group health plan enters into a contract with a qualified external appeal
entity for the conduct of external appeal activities in accordance with
section 104 of such Act, the plan shall be treated as meeting the
requirement of such section and is not liable for the entity's failure to
meet any requirements under such section.
`(5) APPLICATION TO PROHIBITIONS- Pursuant to rules of the Secretary, if
a health insurance issuer offers health insurance coverage in connection
with a group health plan and takes an action in violation of any of the
following sections of the Bipartisan Patient Protection Act of 2001, the
group health plan shall not be liable for such violation unless the plan
caused such violation:
`(A) Section 131 (relating to prohibition of interference with certain
medical communications).
`(B) Section 132 (relating to prohibition of discrimination against
providers based on licensure).
`(C) Section 133 (relating to prohibition against improper incentive
arrangements).
`(D) Section 135 (relating to protection for patient
advocacy).
`(6) CONSTRUCTION- Nothing in this subsection shall be construed to
affect or modify the responsibilities of the fiduciaries of a group health
plan under part 4 of subtitle B.
`(7) TREATMENT OF SUBSTANTIALLY EQUIVALENT STATE LAWS- For purposes of
applying this subsection, any reference in this subsection to a requirement
in a section or other provision in the Bipartisan Patient Protection Act of
2001 with respect to a health insurance issuer is deemed to include a
reference to a requirement under a State law that is substantially
equivalent (as determined under section 152(c) of such Act) to the
requirement in such section or other provisions.
`(8) APPLICATION TO CERTAIN PROHIBITIONS AGAINST RETALIATION- With
respect to compliance with the requirements of section 135(b)(1) of the
Bipartisan Patient Protection Act of 2001, for purposes of this subtitle the
term `group health plan' is deemed to include a reference to an
institutional health care provider.
`(c) ENFORCEMENT OF CERTAIN REQUIREMENTS-
`(1) COMPLAINTS- Any protected health care professional who believes
that the professional has been retaliated or discriminated against in
violation of section 135(b)(1) of the Bipartisan Patient Protection Act of
2001 may file with the Secretary a complaint within 180 days of the date of
the alleged retaliation or discrimination.
`(2) INVESTIGATION- The Secretary shall investigate such complaints and
shall determine if a violation of such section has occurred and, if so,
shall issue an order to ensure that the protected health care professional
does not suffer any loss of position, pay, or benefits in relation to the
plan, issuer, or provider involved, as a result of the violation found by
the Secretary.
`(d) CONFORMING REGULATIONS- The Secretary shall issue regulations to
coordinate the requirements on group health plans and health insurance issuers
under this section with the requirements imposed under the other provisions of
this title. In order to reduce duplication and clarify the rights of
participants and beneficiaries with respect to information that is required to
be provided, such regulations shall coordinate the information disclosure
requirements under section 121 of the Bipartisan Patient Protection Act of
2001 with the reporting and disclosure requirements imposed under part 1, so
long as such coordination does not result in any reduction in the information
that would otherwise be provided to participants and beneficiaries.'.
(b) SATISFACTION OF ERISA CLAIMS PROCEDURE REQUIREMENT- Section 503 of
such Act (29 U.S.C. 1133) is amended by inserting `(a)' after `SEC. 503.' and
by adding at the end the following new subsection:
`(b) In the case of a group health plan (as defined in section 733)
compliance with the requirements of subtitle A of title I of the Bipartisan
Patient Protection Act of 2001, and compliance with regulations promulgated by
the Secretary, in the case of a claims denial shall be deemed compliance with
subsection (a) with respect to such claims denial.'.
(c) CONFORMING AMENDMENTS- (1) Section 732(a) of such Act (29 U.S.C.
1185(a)) is amended by striking `section 711' and inserting `sections 711 and
714'.
(2) The table of contents in section 1 of such Act is amended by inserting
after the item relating to section 713 the following new item:
`Sec. 714. Patient protection standards.'.
(3) Section 502(b)(3) of such Act (29 U.S.C. 1132(b)(3)) is amended by
inserting `(other than section 135(b))' after `part 7'.
SEC. 302. AVAILABILITY OF CIVIL REMEDIES.
(a) AVAILABILITY OF FEDERAL CIVIL REMEDIES IN CASES NOT INVOLVING
MEDICALLY REVIEWABLE DECISIONS-
(1) IN GENERAL- Section 502 of the Employee Retirement Income Security
Act of 1974 (29 U.S.C. 1132) is amended by adding at the end the following
new subsection:
`(n) CAUSE OF ACTION RELATING TO PROVISION OF HEALTH BENEFITS-
`(1) IN GENERAL- In any case in which--
`(A) a person who is a fiduciary of a group health plan, a health
insurance issuer offering health insurance coverage in connection with the
plan, or an agent of the plan, issuer, or plan sponsor--
`(i) upon consideration of a claim for benefits of a participant or
beneficiary under section 102 of the Bipartisan Patient Protection Act
of 2001 (relating to procedures for initial claims for benefits and
prior authorization determinations) or upon review of a denial of such a
claim under section 103 of such Act (relating to internal appeal of a
denial of a claim for benefits), fails to exercise ordinary care in
making a decision--
`(I) regarding whether an item or service is covered under the
terms and conditions of the plan or coverage,
`(II) regarding whether an individual is a participant or
beneficiary who is enrolled under the terms and conditions of the plan
or coverage (including the applicability of any waiting period under
the plan or coverage), or
`(III) as to the application of cost-sharing requirements or the
application of a specific exclusion or express limitation on the
amount, duration, or scope of coverage of items or services under the
terms and conditions of the plan or coverage, or
`(ii) otherwise fails to exercise ordinary care in the performance
of a duty under the terms and conditions of the plan with respect to a
participant or beneficiary, and
`(B) such failure is a proximate cause of personal injury to, or the
death of, the participant or beneficiary,
such person shall be liable to the participant or beneficiary (or the
estate of such participant or beneficiary) for economic and noneconomic
damages (but not exemplary or punitive damages) in connection with such
personal injury or death.
`(2) CAUSE OF ACTION MUST NOT INVOLVE MEDICALLY REVIEWABLE
DECISION-
`(A) IN GENERAL- A cause of action is established under paragraph
(1)(A) only if the decision referred to in clause (i) or the failure
described in clause (ii) does not include a medically reviewable
decision.
`(B) MEDICALLY REVIEWABLE DECISION- For purposes of subparagraph (A),
the term `medically reviewable decision' means a denial of a claim for
benefits under the plan which is described in section 104(d)(2) of the
Bipartisan Patient Protection Act of 2001 (relating to medically
reviewable decisions).
`(3) DEFINITIONS- For purposes of this subsection-
`(A) ORDINARY CARE- The term `ordinary care' means--
`(i) with respect to a determination on a claim for benefits, that
degree of care, skill, and diligence that a reasonable and prudent
individual would exercise in making a fair determination on a claim for
benefits of like kind to the claim involved; and
`(ii) with respect to the performance of a duty, that degree of
care, skill, and diligence that a reasonable and prudent individual
would exercise in performing the duty or a duty of like
character.
`(B) PERSONAL INJURY- The term `personal injury' means a physical
injury and includes an injury arising out of the treatment (or failure to
treat) a mental illness or disease.
`(C) CLAIM FOR BENEFITS; DENIAL- The terms `claim for benefits' and
`denial of a claim for benefits' have the meanings provided such terms in
section 102(e) of the Bipartisan Patient Protection Act of 2001.
`(D) TERMS AND CONDITIONS- The term `terms and conditions' includes,
with respect to a group health plan or health insurance coverage,
requirements imposed under title I of the Bipartisan Patient Protection
Act of 2001 or under part 6 or 7.
`(E) GROUP HEALTH PLAN AND OTHER RELATED TERMS- The provisions of
sections 732(d) and 733 apply for purposes of this subsection in the same
manner as they apply for purposes of part 7, except that the term `group
health plan' includes a group health plan (as defined in section
607(1)).
`(4) EXCLUSION OF EMPLOYERS AND OTHER PLAN SPONSORS-
`(A) CAUSES OF ACTION AGAINST EMPLOYERS AND PLAN SPONSORS PRECLUDED-
Subject to subparagraph (B), paragraph (1)(A) does not authorize a cause
of action against an employer or other plan sponsor maintaining the plan
(or against an employee of such an employer or sponsor acting within the
scope of employment).
`(B) CERTAIN CAUSES OF ACTION PERMITTED- Notwithstanding subparagraph
(A), a cause of action may arise against an employer or other plan sponsor
(or against an employee
of such an employer or sponsor acting within the scope of employment)--
`(i) under clause (i) of paragraph (1)(A), to the extent there was
direct participation by the employer or other plan sponsor (or employee)
in the decision of the plan under section 102 of the Bipartisan Patient
Protection Act of 2001 upon consideration of a claim for benefits or
under section 103 of such Act upon review of a denial of a claim for
benefits, or
`(ii) under clause (ii) of paragraph (1)(A), to the extent there was
direct participation by the employer or other plan sponsor (or employee)
in the failure described in such clause.
`(C) DIRECT PARTICIPATION-
`(i) DIRECT PARTICIPATION IN DECISIONS- For purposes of subparagraph
(B), the term `direct participation' means, in connection with a
decision described in clause (i) of paragraph (1)(A) or a failure
described in clause (ii) of such paragraph, the actual making of such
decision or the actual exercise of control in making such decision or in
the conduct constituting the failure.
`(ii) RULES OF CONSTRUCTION- For purposes of clause (i), the
employer or plan sponsor (or employee) shall not be construed to be
engaged in direct participation because of any form of decisionmaking or
other conduct that is merely collateral or precedent to the decision
described in clause (i) of paragraph (1)(A) on a particular claim for
benefits of a participant or beneficiary or that is merely collateral or
precedent to the conduct constituting a failure described in clause (ii)
of paragraph (1)(A) with respect to a particular participant or
beneficiary, including (but not limited to)--
`(I) any participation by the employer or other plan sponsor (or
employee) in the selection of the group health plan or health
insurance coverage involved or the third party administrator or other
agent;
`(II) any engagement by the employer or other plan sponsor (or
employee) in any cost-benefit analysis undertaken in connection with
the selection of, or continued maintenance of, the plan or coverage
involved;
`(III) any participation by the employer or other plan sponsor (or
employee) in the process of creating, continuing, modifying, or
terminating the plan or any benefit under the plan, if such process
was not substantially focused solely on the particular situation of
the participant or beneficiary referred to in paragraph (1)(A);
and
`(IV) any participation by the employer or other plan sponsor (or
employee) in the design of any benefit under the plan, including the
amount of copayment and limits connected with such
benefit.
`(iv) IRRELEVANCE OF CERTAIN COLLATERAL EFFORTS MADE BY EMPLOYER OR
PLAN SPONSOR- For purposes of this subparagraph, an employer or plan
sponsor shall not be treated as engaged in direct participation in a
decision with respect to any claim for benefits or denial thereof in the
case of any particular participant or beneficiary solely by reason
of--
`(I) any efforts that may have been made by the employer or plan
sponsor to advocate for authorization of coverage for that or any
other participant or beneficiary (or any group of participants or
beneficiaries), or
`(II) any provision that may have been made by the employer or
plan sponsor for benefits which are not covered under the terms and
conditions of the plan for that or any other participant or
beneficiary (or any group of participants or
beneficiaries).
`(5) REQUIREMENT OF EXHAUSTION-
`(A) IN GENERAL- Except as provided in this paragraph, a cause of
action may not be brought under paragraph (1) in connection with any
denial of a claim for benefits of any individual until all administrative
processes under sections 102 and 103 of the Bipartisan Patient Protection
Act of 2001 (if applicable) have been exhausted.
`(B) LATE MANIFESTATION OF INJURY- The requirements under subparagraph
(A) for a cause of action in connection with any denial of a claim for
benefits shall be deemed satisfied, notwithstanding any failure to timely
commence review under section 103 with respect to the denial, if the
personal injury is first known (or first reasonably should have been
known) to the individual (or the death occurs) after the latest date by
which the applicable requirements of subparagraph (A) can be met in
connection with such denial.
`(C) OCCURRENCE OF IMMEDIATE AND IRREPARABLE HARM OR DEATH PRIOR TO
COMPLETION OF PROCESS-
`(i) IN GENERAL- The requirements of subparagraph (A) shall not
apply if the action involves an allegation that immediate and
irreparable harm or death was, or would be, caused by the denial of a
claim for benefits prior to the completion of the administrative
processes referred to in subparagraph (A) with respect to such
denial.
`(ii) CONSTRUCTION- Nothing in clause (i) shall be construed to
preclude--
`(I) continuation of such processes to their conclusion if so
moved by any party, and
`(II) consideration in such action of the final decisions issued
in such processes.
`(iii) DEFINITION- In clause (i), the term `irreparable harm', with
respect to an individual, means an injury or condition that, regardless
of whether the individual receives the treatment that is the subject of
the denial, cannot be repaired in a manner that would restore the
individual to the individual's pre-injured condition.
`(D) RECEIPT OF BENEFITS DURING APPEALS PROCESS- Receipt by the
participant or beneficiary of the benefits involved in the claim for
benefits during the pendency of any administrative processes referred to
in subparagraph (A) or of any action commenced under this
subsection--
`(i) shall not preclude continuation of all such administrative
processes to their conclusion if so moved by any party, and
`(ii) shall not preclude any liability under subsection (a)(1)(C)
and this subsection in connection with such claim.
The court in any action commenced under this subsection shall take
into account any receipt of benefits during such administrative processes
or such action in determining the amount of the damages awarded.
`(A) IN GENERAL- The remedies set forth in this subsection (n) shall
be the exclusive remedies for causes of action brought under this
subsection.
`(B) ASSESSMENT OF CIVIL PENALTIES- In addition to the remedies
provided for in paragraph (1) (relating to the failure to provide contract
benefits in accordance with the plan), a civil assessment, in an amount
not to exceed $5,000,000, payable to the claimant may be awarded in any
action under such paragraph if the claimant establishes by clear and
convincing evidence that the alleged conduct carried out by the defendant
demonstrated bad faith and flagrant disregard for the rights of the
participant or beneficiary under the plan and was a proximate cause of the
personal injury or death that is the subject of the claim.
`(7) LIMITATION OF ACTION- Paragraph (1) shall not apply in connection
with any action commenced after 3 years after the later of--
`(A) the date on which the plaintiff first knew, or reasonably should
have known, of the personal injury or death resulting from the failure
described in paragraph (1), or
`(B) the date as of which the requirements of paragraph (5) are first
met.
`(8) TOLLING PROVISION- The statute of limitations for any cause of
action arising under State law relating to a denial of a claim for benefits
that is the subject of an action brought in Federal court under this
subsection shall be tolled until such time as the Federal court makes a
final disposition, including all appeals, of whether such claim should
properly be within the jurisdiction of the Federal court. The tolling period
shall be determined by the applicable Federal or State law, whichever period
is greater.
`(9) PURCHASE OF INSURANCE TO COVER LIABILITY- Nothing in section 410
shall be construed to preclude the purchase by a group health plan of
insurance to cover any liability or losses arising under a cause of action
under subsection (a)(1)(C) and this subsection.
`(10) EXCLUSION OF DIRECTED RECORDKEEPERS-
`(A) IN GENERAL- Subject to subparagraph (C), paragraph (1) shall not
apply with respect to a directed recordkeeper in connection with a group
health plan.
`(B) DIRECTED RECORDKEEPER- For purposes of this paragraph, the term
`directed recordkeeper' means, in connection with a group health plan, a
person engaged in directed recordkeeping activities pursuant to the
specific instructions of the plan or the employer or other plan sponsor,
including the distribution of enrollment information and distribution of
disclosure materials under this Act or title I of the Bipartisan Patient
Protection Act of 2001 and whose duties do not include making decisions on
claims for benefits.
`(C) LIMITATION- Subparagraph (A) does not apply in connection with
any directed recordkeeper to the extent that the directed recordkeeper
fails to follow the specific instruction of the plan or the employer or
other plan sponsor.
`(11) NO EFFECT ON STATE LAW- No provision of State law (as defined in
section 514(c)(1)) shall be treated as superseded or otherwise altered,
amended, modified, invalidated, or impaired by reason of the provisions of
subsection (a)(1)(C) and this subsection.'.
(2) CONFORMING AMENDMENT- Section 502(a)(1) of such Act (29 U.S.C.
1132(a)(1)) is amended--
(A) by striking `or' at the end of subparagraph (A);
(B) in subparagraph (B), by striking `plan;' and inserting `plan, or';
and
(C) by adding at the end the following new subparagraph:
`(C) for the relief provided for in subsection (n) of this
section.'.
(b) RULES RELATING TO ERISA PREEMPTION- Section 514 of the Employee
Retirement Income Security Act of 1974 (29 U.S.C. 1144) is amended--
(1) by redesignating subsection (d) as subsection (f); and
(2) by inserting after subsection (c) the following new
subsections:
`(d) PREEMPTION NOT TO APPLY TO CAUSES OF ACTION UNDER STATE LAW INVOLVING
MEDICALLY REVIEWABLE DECISION-
`(1) NON-PREEMPTION OF CERTAIN CAUSES OF ACTION-
`(A) IN GENERAL- Except as provided in this subsection, nothing in
this title (including section 502) shall be construed to supersede or
otherwise alter, amend, modify, invalidate, or impair any cause of action
under State law of a participant or beneficiary under a group health plan
(or the estate of such a participant or beneficiary) to recover damages
resulting from personal injury or for wrongful death against any person if
such cause of action arises by reason of a medically reviewable
decision.
`(B) MEDICALLY REVIEWABLE DECISION- For purposes of subparagraph (A),
the term `medically reviewable decision' means a denial of a claim for
benefits under the plan which is described in section 104(d)(2) of the
Bipartisan Patient Protection Act of 2001 (relating to medically
reviewable decisions).
`(C) LIMITATION ON PUNITIVE DAMAGES-
`(i) IN GENERAL- Except as provided in clauses (ii) and (iii), with
respect to a cause of action described in subparagraph (A) brought with
respect to a participant or beneficiary, State law is superseded insofar
as it provides any punitive, exemplary, or similar damages if, as of the
time of the personal injury or death, all the requirements of the
following sections of the Bipartisan Patient Protection Act of 2001 were
satisfied with respect to the participant or beneficiary:
`(I) Section 102 (relating to procedures for initial claims for
benefits and prior authorization determinations).
`(II) Section 103 of such Act (relating to internal appeals of
claims denials).
`(III) Section 104 of such Act (relating to independent external
appeals procedures).
`(ii) EXCEPTION FOR CERTAIN ACTIONS FOR WRONGFUL DEATH- Clause (i)
shall not apply with respect to an action for wrongful death if the
applicable State law provides (or has been construed to provide) for
damages in such an action which are only punitive or exemplary in
nature.
`(iii) EXCEPTION FOR WILLFUL OR WANTON DISREGARD FOR THE RIGHTS OR
SAFETY OF OTHERS- Clause (i) shall not apply with respect to any cause
of action described in subparagraph (A) if, in such action, the
plaintiff establishes by clear and convincing evidence that conduct
carried out by the defendant with willful or wanton disregard for the
rights or safety of others was a proximate cause of the personal injury
or wrongful death that is the subject of the action.
`(2) DEFINITIONS- For purposes of this subsection and subsection
(e)--
`(A) GROUP HEALTH PLAN AND OTHER RELATED TERMS- The provisions of
sections 732(d) and 733 apply for purposes of this subsection in the same
manner as they apply for purposes of part 7, except that the term `group
health plan' includes a group health plan (as defined in section
607(1)).
`(B) PERSONAL INJURY- The term `personal injury' means a physical
injury and includes an injury arising out of the treatment (or failure to
treat) a mental illness or disease.
`(C) CLAIM FOR BENEFIT; DENIAL- The terms `claim for benefits' and
`denial of a claim for benefits' shall have the meaning provided such
terms under section 102(e) of the Bipartisan Patient Protection Act of
2001.
`(3) EXCLUSION OF EMPLOYERS AND OTHER PLAN SPONSORS-
`(A) CAUSES OF ACTION AGAINST EMPLOYERS AND PLAN SPONSORS PRECLUDED-
Subject to subparagraph (B), paragraph (1) does not apply with respect
to--
`(i) any cause of action against an employer or other plan sponsor
maintaining the plan (or against an employee of such an employer or
sponsor acting within the scope of employment), or
`(ii) a right of recovery, indemnity, or contribution by a person
against an employer or other plan sponsor (or such an employee) for
damages assessed against the person pursuant to a cause of action to
which paragraph (1) applies.
`(B) CERTAIN CAUSES OF ACTION PERMITTED- Notwithstanding subparagraph
(A), paragraph (1) applies with respect to any cause of action described
in paragraph (1) maintained by a participant or beneficiary against an
employer or other plan sponsor (or against an employee of such an employer
or sponsor acting within the scope of employment)--
`(i) in the case of any cause of action based on a decision of the
plan under section 102 of the Bipartisan Patient Protection Act of 2001
upon consideration of a claim for benefits or under section 103 of such
Act upon review of a denial of a claim for benefits, to the extent there
was direct participation by the employer or other plan sponsor (or
employee) in the decision, or
`(ii) in the case of any cause of action based on a failure to
otherwise perform a duty under the terms and conditions of the plan with
respect to a claim for benefits of a participant or beneficiary, to the
extent there was direct participation by the employer or other plan
sponsor (or employee) in the failure.
`(C) DIRECT PARTICIPATION-
`(i) DIRECT PARTICIPATION IN DECISIONS- For purposes of subparagraph
(B), the term `direct participation' means, in connection with a
decision described in subparagraph (B)(i) or a failure described in
subparagraph (B)(ii), the actual making of such decision or the actual
exercise of control in making such decision or in the conduct
constituting the failure.
`(ii) RULES OF CONSTRUCTION- For purposes of clause (i), the
employer or plan sponsor (or employee) shall not be construed to be
engaged in direct participation
because of any form of decisionmaking or other conduct that is merely
collateral or precedent to the decision described in subparagraph (B)(i) on a
particular claim for benefits of a particular participant or beneficiary or that
is merely collateral or precedent to the conduct constituting a failure
described in subparagraph (B)(ii) with respect to a particular participant or
beneficiary, including (but not limited to)--
`(I) any participation by the employer or other plan sponsor (or
employee) in the selection of the group health plan or health
insurance coverage involved or the third party administrator or other
agent;
`(II) any engagement by the employer or other plan sponsor (or
employee) in any cost-benefit analysis undertaken in connection with
the selection of, or continued maintenance of, the plan or coverage
involved;
`(III) any participation by the employer or other plan sponsor (or
employee) in the process of creating, continuing, modifying, or
terminating the plan or any benefit under the plan, if such process
was not substantially focused solely on the particular situation of
the participant or beneficiary referred to in paragraph (1)(A);
and
`(IV) any participation by the employer or other plan sponsor (or
employee) in the design of any benefit under the plan, including the
amount of copayment and limits connected with such
benefit.
`(iii) IRRELEVANCE OF CERTAIN COLLATERAL EFFORTS MADE BY EMPLOYER OR
PLAN SPONSOR- For purposes of this subparagraph, an employer or plan
sponsor shall not be treated as engaged in direct participation in a
decision with respect to any claim for benefits or denial thereof in the
case of any particular participant or beneficiary solely by reason
of--
`(I) any efforts that may have been made by the employer or plan
sponsor to advocate for authorization of coverage for that or any
other participant or beneficiary (or any group of participants or
beneficiaries), or
`(II) any provision that may have been made by the employer or
plan sponsor for benefits which are not covered under the terms and
conditions of the plan for that or any other participant or
beneficiary (or any group of participants or
beneficiaries).
`(4) REQUIREMENT OF EXHAUSTION-
`(A) IN GENERAL- Except as provided in this paragraph, paragraph (1)
shall not apply with respect to a cause of action described in such
paragraph in connection with any denial of a claim for benefits of any
individual until all administrative processes under sections 102, 103, and
104 of the Bipartisan Patient Protection Act of 2001 (if applicable) have
been exhausted.
`(B) LATE MANIFESTATION OF INJURY- The requirements under subparagraph
(A) for a cause of action in connection with any denial of a claim for
benefits shall be deemed satisfied, notwithstanding any failure to timely
commence review under section 103 or 104 with respect to the denial, if
the personal injury is first known (or first should have been known) to
the individual (or the death occurs) after the latest date by which the
applicable requirements of subparagraph (A) can be met in connection with
such denial.
`(C) OCCURRENCE OF IMMEDIATE AN IRREPARABLE HARM OR DEATH PRIOR TO
COMPLETION OF PROCESS-
`(i) IN GENERAL- The requirements of subparagraph (A) shall not
apply if the action involves an allegation that immediate and
irreparable harm or death was, or would be, caused by the denial of a
claim for benefits prior to the completion of the administrative
processes referred to in subparagraph (A) with respect to such
denial.
`(ii) CONSTRUCTION- Nothing in clause (i) shall be construed to
preclude--
`(I) continuation of such processes to their conclusion if so
moved by any party, and
`(II) consideration in such action of the final decisions issued
in such processes.
`(iii) DEFINITION- In clause (i), the term `irreparable harm', with
respect to an individual, means an injury or condition that, regardless
of whether the individual receives the treatment that is the subject of
the denial, cannot be repaired in a manner that would restore the
individual to the individual's pre-injured condition.
`(D) RECEIPT OF BENEFITS DURING APPEALS PROCESS- Receipt by the
participant or beneficiary of the benefits involved in the claim for
benefits during the pendency of any administrative processes referred to
in subparagraph (A) or of any action commenced under this
subsection--
`(i) shall not preclude continuation of all such administrative
processes to their conclusion if so moved by any party, and
`(ii) shall not preclude any liability under subsection (a)(1)(C)
and this subsection in connection with such claim.
`(5) TOLLING PROVISION- The statute of limitations for any cause of
action arising under section 502(n) relating to a denial of a claim for
benefits that is the subject of an action brought in State court shall be
tolled until such time as the State court makes a final disposition,
including all appeals, of whether such claim should properly be within the
jurisdiction of the State court. The tolling period shall be determined by
the applicable Federal or State law, whichever period is greater.
`(6) EXCLUSION OF DIRECTED RECORDKEEPERS-
`(A) IN GENERAL- Subject to subparagraph (C), paragraph (1) shall not
apply with respect to a directed recordkeeper in connection with a group
health plan.
`(B) DIRECTED RECORDKEEPER- For purposes of this paragraph, the term
`directed recordkeeper' means, in connection with a group health plan, a
person engaged in directed recordkeeping activities pursuant to the
specific instructions of the plan or the employer or other plan sponsor,
including the distribution of enrollment information and distribution of
disclosure materials under this Act or title I of the
Bipartisan Patient Protection Act of 2001 and whose duties do not include
making decisions on claims for benefits.
`(C) LIMITATION- Subparagraph (A) does not apply in connection with
any directed recordkeeper to the extent that the directed recordkeeper
fails to follow the specific instruction of the plan or the employer or
other plan sponsor.
`(7) CONSTRUCTION- Nothing in this subsection shall be construed
as--
`(A) saving from preemption a cause of action under State law for the
failure to provide a benefit for an item or service which is specifically
excluded under the group health plan involved, except to the extent
that--
`(i) the application or interpretation of the exclusion involves a
determination described in section 104(d)(2) of the Bipartisan Patient
Protection Act of 2001, or
`(ii) the provision of the benefit for the item or service is
required under Federal law or under applicable State law consistent with
subsection (b)(2)(B);
`(B) preempting a State law which requires an affidavit or certificate
of merit in a civil action;
`(C) affecting a cause of action or remedy under State law in
connection with the provision or arrangement of excepted benefits (as
defined in section 733(c)), other than those described in section
733(c)(2)(A); or
`(D) affecting a cause of action under State law other than a cause of
action described in paragraph (1)(A).
`(8) PURCHASE OF INSURANCE TO COVER LIABILITY- Nothing in section 410
shall be construed to preclude the purchase by a group health plan of
insurance to cover any liability or losses arising under a cause of action
described in paragraph (1)(A).
`(e) RULES OF CONSTRUCTION RELATING TO HEALTH CARE- Nothing in this title
shall be construed as--
`(1) affecting any State law relating to the practice of medicine or the
provision of medical care, or affecting any action based upon such a State
law,
`(2) superseding any State law permitted under section 152(b)(1)(A) of
the Bipartisan Patient Protection Act of 2001, or
`(3) affecting any applicable State law with respect to limitations on
monetary damages.'.
(c) EFFECTIVE DATE- The amendments made by this section shall apply to
acts and omissions (from which a cause of action arises) occurring on or after
the date of the enactment of this Act.
SEC. 303. LIMITATIONS ON ACTIONS.
Section 502 of the Employee Retirement Income Security Act of 1974 (29
U.S.C. 1132) (as amended by section 302(a)) is amended further by adding at
the end the following new subsection:
`(o) LIMITATIONS ON ACTIONS RELATING TO GROUP HEALTH PLANS-
`(1) IN GENERAL- Except as provided in paragraph (2), no action may be
brought under subsection (a)(1)(B), (a)(2), or (a)(3) by a participant or
beneficiary seeking relief based on the application of any provision in
section 101, subtitle B, or subtitle D of title I of the Bipartisan Patient
Protection Act of 2001 (as incorporated under section 714).
`(2) CERTAIN ACTIONS ALLOWABLE- An action may be brought under
subsection (a)(1)(B), (a)(2), or (a)(3) by a participant or beneficiary
seeking relief based on the application of section 101, 113, 114, 115, 116,
117, 118(a)(3), 119, or 120 of the Bipartisan Patient Protection Act of 2001
(as incorporated under section 714) to the individual circumstances of that
participant or beneficiary, except that--
`(A) such an action may not be brought or maintained as a class
action; and
`(B) in such an action, relief may only provide for the provision of
(or payment of) benefits, items, or services denied to the individual
participant or beneficiary involved (and for attorney's fees and the costs
of the action, at the discretion of the court) and shall not provide for
any other relief to the participant or beneficiary or for any relief to
any other person.
`(3) OTHER PROVISIONS UNAFFECTED- Nothing in this subsection shall be
construed as affecting subsections (a)(1)(C) and (n) or section
514(d).
`(4) ENFORCEMENT BY SECRETARY UNAFFECTED- Nothing in this subsection
shall be construed as affecting any action brought by the Secretary.'.
TITLE IV--AMENDMENTS TO THE INTERNAL REVENUE CODE OF 1986
SEC. 401. APPLICATION TO GROUP HEALTH PLANS UNDER THE INTERNAL REVENUE CODE
OF 1986.
Subchapter B of chapter 100 of the Internal Revenue Code of 1986 is
amended--
(1) in the table of sections, by inserting after the item relating to
section 9812 the following new item:
`Sec. 9813. Standard relating to patients' bill of rights.';
(2) by inserting after section 9812 the following:
`SEC. 9813. STANDARD RELATING TO PATIENTS' BILL OF RIGHTS.
`A group health plan shall comply with the requirements of title I of the
Bipartisan Patient Protection Act of 2001 (as in effect as of the date of the
enactment of such Act), and such requirements shall be deemed to be
incorporated into this section.'.
SEC. 402. CONFORMING ENFORCEMENT FOR WOMEN'S HEALTH AND CANCER RIGHTS.
Subchapter B of chapter 100 of the Internal Revenue Code of 1986, as
amended by section 401, is further amended--
(1) in the table of sections, by inserting after the item relating to
section 9813 the following new item:
`Sec. 9814. Standard relating to women's health and cancer rights.';
(2) by inserting after section 9813 the following:
`SEC. 9814. STANDARD RELATING TO WOMEN'S HEALTH AND CANCER RIGHTS.
`The provisions of section 713 of the Employee Retirement Income Security
Act of 1974 (as in effect as of the date of the enactment of this section)
shall apply to group health plans as if included in this subchapter.'.
TITLE V--EFFECTIVE DATES; COORDINATION IN IMPLEMENTATION
SEC. 501. EFFECTIVE DATES.
(a) GROUP HEALTH COVERAGE-
(1) IN GENERAL- Subject to paragraph (2) and subsection (d), the
amendments made by sections 201(a), 301, 303, and 401 and 402 (and title I
insofar as it relates to such sections) shall apply with respect to group
health plans, and health insurance coverage offered in connection with group
health plans, for plan years beginning on or after January 1, 2002 (in this
section referred to as the `general effective date').
(2) TREATMENT OF COLLECTIVE BARGAINING AGREEMENTS- In the case of a
group health plan maintained pursuant to one or more collective bargaining
agreements between employee representatives and one or more employers
ratified before the date of the enactment of this Act, the amendments made
by sections 201(a), 301, 303, and 401 and 402 (and title I insofar as it
relates to such sections) shall not apply to plan years beginning before the
later of--
(A) the date on which the last collective bargaining agreements
relating to the plan terminates (determined without regard to any
extension thereof agreed to after the date of the enactment of this Act);
or
(B) the general effective date.
For purposes of subparagraph (A), any plan amendment made pursuant to a
collective bargaining agreement relating to the plan which amends the plan
solely to conform to any requirement added by this division shall not be
treated as a termination of such collective bargaining agreement.
(b) INDIVIDUAL HEALTH INSURANCE COVERAGE- Subject to subsection (d), the
amendments made by section 202 shall apply with respect to individual health
insurance coverage offered, sold, issued, renewed, in effect, or operated in
the individual market on or after the general effective date.
(c) TREATMENT OF RELIGIOUS NONMEDICAL PROVIDERS-
(1) IN GENERAL- Nothing in this Act (or the amendments made thereby)
shall be construed to--
(A) restrict or limit the right of group health plans, and of health
insurance issuers offering health insurance coverage, to include as
providers religious nonmedical providers;
(B) require such plans or issuers to--
(i) utilize medically based eligibility standards or criteria in
deciding provider status of religious nonmedical providers;
(ii) use medical professionals or criteria to decide patient access
to religious nonmedical providers;
(iii) utilize medical professionals or criteria in making decisions
in internal or external appeals regarding coverage for care by religious
nonmedical providers; or
(iv) compel a participant or beneficiary to undergo a medical
examination or test as a condition of receiving health insurance
coverage for treatment by a religious nonmedical provider;
or
(C) require such plans or issuers to exclude religious nonmedical
providers because they do not provide medical or other required data, if
such data is inconsistent with the religious nonmedical treatment or
nursing care provided by the provider.
(2) RELIGIOUS NONMEDICAL PROVIDER- For purposes of this subsection, the
term `religious nonmedical provider' means a provider who provides no
medical care but who provides only religious nonmedical treatment or
religious nonmedical nursing care.
(d) TRANSITION FOR NOTICE REQUIREMENT- The disclosure of information
required under section 121 of this Act shall first be provided pursuant
to--
(1) subsection (a) with respect to a group health plan that is
maintained as of the general effective date, not later than 30 days before
the beginning of the first plan year to which title I applies in connection
with the plan under such subsection; or
(2) subsection (b) with respect to a individual health insurance
coverage that is in effect as of the general effective date, not later than
30 days before the first date as of which title I applies to the coverage
under such subsection.
SEC. 502. COORDINATION IN IMPLEMENTATION.
The Secretary of Labor, the Secretary of Health and Human Services, and
the Secretary of the Treasury shall ensure, through the execution of an
interagency memorandum of understanding among such Secretaries, that--
(1) regulations, rulings, and interpretations issued by such Secretaries
relating to the same matter over which such Secretaries have responsibility
under the provisions of this division (and the amendments made thereby) are
administered so as to have the same effect at all times; and
(2) coordination of policies relating to enforcing the same requirements
through such Secretaries in order to have a coordinated enforcement strategy
that avoids duplication of enforcement efforts and assigns priorities in
enforcement.
SEC. 503. SEVERABILITY.
If any provision of this Act, an amendment made by this Act, or the
application of such provision or amendment to any person or circumstance is
held to be unconstitutional, the remainder of this Act, the amendments made by
this Act, and the application of the provisions of such to any person or
circumstance shall not be affected thereby.
END